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Worldwide, bacterial vaginosis (BV) is the most common vaginal disorder in 
women of childbearing age.  BV is of major clinical importance due to its ability to 
significantly affect pregnancy outcome and enhance the transmission and acquisition of 
HIV.  BV is characterized by a dramatic shift in the vaginal microflora; in most BV cases, 
the predominant bacterial species is Gardnerella vaginalis.  It has been demonstrated that 
G. vaginalis forms an adherent biofilm on the vaginal epithelium of women with BV.  
Furthemore, evidence suggests that the high rate of recurrence associated with BV is 
  xvi 
related to incomplete eradication of the biofilm.  The overall goal of this study was to 
characterize G. vaginalis virulence properties, including biofilm formation, in order to 
better understand the pathogenesis of BV and to improve available treatment methods. 
In an effort to tease apart the uncertain etiology of this disorder, we utilized in vitro 
assays to compare three virulence properties of G. vaginalis relative to other BV-
associated anaerobes.  Only G. vaginalis demonstrated all three virulence properties, 
including robust biofilm formation.  It has been shown that the biofilm phenotype allows 
its constituent bacteria to be resistant to many negative environmental stimuli.  Therefore, 
we studied the susceptibilities of biofilm vs. planktonic cultures to H2O2 and lactic acid.  
Biofilms tolerated higher concentrations of both chemicals; however, when the biofilm 
was proteolytically disrupted, sensitivity to the chemicals returned to planktonic levels.   
Since our data suggested a critical role for a protein in biofilm formation, a partial 
genome sequence of G. vaginalis was searched for sequence homology to known biofilm 
adhesins using the tBLASTn program.  This revealed an open-reading frame encoding a 
hypothetical protein with significant homology to the staphylococcal Bap protein.  
Antibody towards a portion of the identified gene product was produced in rabbits by 
inoculation of a recombinant peptide to an antigenic region of the protein.  Antibody 
inhibition assays against biofilm formation, adherence, initial adherence and aggregation 
were conducted.  Relative expression levels of the biofilm-associated protein were 
analyzed under different conditions by western blot analysis.  Finally, the protein was 
expressed in heterologous hosts and analyzed for an increase in biofilm formation. 
  1 
CHAPTER 1  
Introduction 
 
Clinical overview 
 
The human vagina is a complex environment, composed of stratified squamous 
nonkeratinized epithelium and its native bacteria. In normal, healthy women, the vagina 
is populated mainly by hydrogen peroxide producing lactobacilli that inhibit the growth 
of other vaginal flora by maintaining the vaginal acidity, competing with other bacterial 
species for space and nutrients, and producing bacteriocins (Eschenbach 1993; Boskey, 
Cone et al. 2001; Atassi, Brassart et al. 2006).  The mild acidity of the healthy vagina has 
been shown to correlate with a decreased risk of trichomoniasis, urinary tract infection 
and infection with genital mycoplasma (Stamey and Timothy 1975; Hanna, Taylor-
Robinson et al. 1985).  One of the hallmarks of bacterial vaginosis (BV) is a reduction in 
vaginal acidity.   
BV is the most prevalent vaginal disorder in women of reproductive age, affecting 
10 to 20% of Caucasian women and 30 to 50% of African American women, although, 
estimates of its prevalence depend on the population studied (Eschenbach 1993; Sobel 
2000).  BV is frequently observed in women attending sexually transmitted disease 
(STD) clinics, where the percentage reaches as high as 40%; however, the disease can 
occur in the absence of sexual intercourse (Sobel 2000).  16-29% of pregnant women are 
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BV positive, although, it is more often detected in women attending infertility clinics 
(Sobel 2000).  
BV is characterized by a loss of protective lactobacilli, an increase in the vaginal 
pH to >4.5, and the proliferation of a variety of anaerobic species.  An increase in the 
prevalence and concentration of Gardnerella vaginalis, Mycoplasma hominis, Atopobium 
vaginae, Prevotella sp., and numerous other gram-positive rods, is characteristic of BV 
(Sobel 2000; Fredricks, Fiedler et al. 2005; Fredricks, Fiedler et al. 2007; Witkin, 
Linhares et al. 2007; Oakley, Fiedler et al. 2008).  Risk factors for BV include sexual 
activity and number of sexual partners, use of intrauterine devices, douching, antibiotic 
treatment and infection with sexually transmitted diseases (Sobel 2000).   
Symptoms of BV can include a thin, grayish-white vaginal discharge with a foul 
odor and mild irritation, absence of inflammatory signs and increased vaginal pH; 
however, many women with BV are asymptomatic (Sobel 2000).  The massive 
overgrowth of anaerobes associated with BV leads to an increased production of 
proteolytic enzymes, which in turn break down vaginal peptides into amines that are 
volatile and malodorous.  These amines are associated with the foul odor of BV and 
squamous epithelial cell exfoliation, creating the typical discharge abundant with clue 
cells.  Clue cells, which are seen in Figure 1, are vaginal epithelial cells that are coated 
by bacteria and are pathognomonic for BV (Eschenbach, Hillier et al. 1988).  BV is 
primarily diagnosed by the Amsel criteria, which includes:  presence of a thin, white 
discharge, positive whiff test with addition of 10% potassium hydroxide, an elevated 
vaginal pH, and the presence of clue cells (Amsel, Totten et al. 1983). 
Figure 1. Photomicrograph of a clue cell.  ME180 vaginal epithelial cells were 
allowed to interact with a G. vaginalis overnight culture for 10 minutes.  The 
bacteria and cells were placed on a microscopy slide, allowed to dry, flamed, then 
gram stained.  Arrows indicate a rough edge of the VECs where bacteria is attached.  
This image is representative of what a clue cell from a patient with BV would look 
like.  (magnification 40X) 
3 
4 
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 BV has been consistently associated with adverse pregnancy outcomes such as 
preterm delivery, low birth weight, postpartum endometritis, as well as other gynecologic 
complications such as pelvic inflammatory disease and vaginal cuff cellulitis (Gravett, 
Hummel et al. 1986; Soper, Bump et al. 1990; Sobel 2000; Larsson, Bergstrom et al. 
2005; Denney and Culhane 2009; Nelson, Hanlon et al. 2009).  Studies by Oleen-Burkey 
et al. and Hillier et al. have detected increased risks of preterm birth ranging from 2.0 to 
6.9 odds ratio directly attributable to BV (Hillier, Nugent et al. 1995; Oleen-Burkey and 
Hillier 1995); however, patients at high risk for preterm delivery who were treated with 
oral metronidazole, all showed considerable reduction in the incidence of preterm labor 
associated with BV (Morales, Schorr et al. 1994; Hauth, Goldenberg et al. 1995; 
McGregor, French et al. 1995; Camargo, Simoes et al. 2005).  Ten trials that evaluated 
the use of metronidazole for routine operative prophylaxis before abortion and 
hysterectomy demonstrated a substantial reduction in postoperative infectious 
complications (Jackson, Ridley et al. 1979; Soper, Bump et al. 1990; Watts, Krohn et al. 
1990; Larsson, Platz-Christensen et al. 1991).  Because of the increased risk of 
postoperative infectious complications associated with BV, some specialists suggest 
screening for BV and treating women before reproductive tract surgeries.     
Importantly, BV has been linked to increased acquisition and transmission of HIV 
(Cohen, Duerr et al. 1995; Sewankambo, Gray et al. 1997; Kapiga, Sam et al. 2007).  In a 
paper by Kapiga et al., they demonstrate a 2-fold higher risk of HIV-1 in women with BV 
than compared to women with normal flora (Kapiga, Sam et al. 2007).  Levels of HIV 
RNA in female genital mucosal fluid are also increased in women with BV, with women 
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with the lowest numbers of lactobacilli having 15.8 fold higher endocervical HIV-1 RNA 
than women with normal lactobacilli levels (Coleman, Hitti et al. 2007).  Normal, healthy 
women with no vaginal disruptions have a low susceptibility to HIV infection because 
they lack suitable HIV-1 host cells; however, BV may increase a women’s risk of HIV 
acquisition by causing leukocytosis and recruitment of potential HIV-sensitive host cells 
into the vagina (Anderson and Hill 1991).  Many BV-associated bacterial pathogens 
produce sialidases and other mucin-degrading enzymes that alter the epithelial layer thus 
weakening the mucosal barrier and increasing the transmission of HIV from infected 
male partners (Larsson, Bergstrom et al. 2005).  Perhaps most importantly, there is a 
decrease in the number of hydrogen-peroxide producing lactobacilli found in the vagina 
of women with BV.  Hydrogen peroxide is not only toxic to a number of microorganisms, 
but capable of inactivating viruses such as HIV as well (Klebanoff and Coombs 1991).  A 
reduction in the amount of hydrogen peroxide in the vagina also leads to an increase in 
vaginal pH and activation of CD4 lymphocytes, or HIV-target cells (Schmid, Markowitz 
et al. 2000).   
The most successful oral therapy for BV remains metronidazole, although 
clindamycin is also used.  The beneficial effect of metronidazole results from its activity 
against anaerobic bacteria and the susceptibility of G. vaginalis to the 
hydroxymetabolites of the antibiotic.  The Centers for Disease Control and Prevention 
(CDC) recommends 500 mg of metronidazole orally twice a day for 7 days.  Topical 
therapy with 2% clindamycin gel once daily for 7 days or 0.75% metronidazole gel once 
daily for 5 days was shown to be as effective as oral metronidazole (Ferris, Litaker et al. 
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1995). Antibiotic therapy can fail in up to 60% of cases (Anukam, Osazuwa et al. 2006) 
and even when effective, BV frequently recurs, with rates as high as 20% within one 
month and 80% within 9 months (Hillier and Holmes 1990; Hay 1998; Beigi, Austin et 
al. 2004).   
Although BV is not considered an inflammatory disorder, several cytokines are 
upregulated.  The abnormal vaginal microbiota associated with BV has been shown to 
increase cytokines like IL-1"/# and IL-8 (Platz-Christensen, Mattsby-Baltzer et al. 1993; 
Wennerholm, Holm et al. 1998).  Cervicovaginal lavage samples (CVL) from women 
with BV were able to induce expression of TNF-" secretion by primary peripheral-blood 
mononuclear cells and monocytic cell lines.  The CVL samples from women with BV 
also increased expression of Toll-like Receptor 4 (TLR-4) mRNA expression up to 60-
fold in cell lines; this suggests a new mechanism whereby BV can affect HIV 
transmission (Zariffard, Novak et al. 2005).  It has been seen that stimulation through 
TLR4 is able to increase HIV expression by infected cells (Equils, Faure et al. 2001; 
Bafica, Scanga et al. 2004); the paper by Zariffard et al. suggests that HIV-infected cells 
present in the genital tract of women with BV may be directly stimulated through TLR4 
to express increased levels of HIV (Zariffard, Novak et al. 2005). 
Not only does an altered microbiota and presence of BV lead to changes in the 
cytokine profile in the vagina, but it also affects the presence of vaginal hydrolytic 
enzymes and certain immunoglobulins found in the vagina.  A paper by Cauci et al. 
showed that pregnant women with BV have higher concentrations of sialidase and 
prolidase, two microbial enzymes that affect the vaginal epithelium integrity (Cauci, Hitti 
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et al. 2002).  In addition, pregnant women with BV have lower antibodies to the 
vaginolysin toxin produced by G. vaginalis than women with normal flora (Cauci, Hitti et 
al. 2002).  The presence of higher than normal sialidase and lower amounts of anti-
vaginolysin antibodies could potentially hamper the local mucosal immune response by 
degrading glycoproteins such as antibodies, or by failing to adequately bind circulating 
toxin (Pilatte, Bignon et al. 1993). 
Although BV is characterized by low levels of lactobacilli and increased numbers 
of anaerobic bacteria, the etiology of BV is poorly understood with no single causative 
agent isolated.  Gardnerella vaginalis, however, has been found to be present in up to 
95% of cases and is found only rarely and in low numbers in healthy women (Gardner 
and Dukes 1955).  To date, BV is still considered a polymicrobial disorder and the 
disruption of normal vaginal flora is not disputable; however, a critical question that 
relates to the sequence of the disruption is whether the loss of protective lactobacilli and 
an increase in vaginal pH must precede the overgrowth of anaerobic bacteria or whether 
anaerobes such as G. vaginalis colonize the vagina leading to a decrease in lactobacilli 
and increased pH.   
 
Gardnerella vaginalis 
 G. vaginalis cells are small, pleomorphic rods, which were once classified as 
Haemophilus sp. by Gardner and Dukes because of their ability to grow on chocolate 
agar (Gardner and Dukes 1955; Catlin 1992).  The tendency to retain the crystal violet 
dye in the Gram reaction and some other corynebacterium-like features, suggested that 
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the organism might be better associated with the genus Corynebacterium, hence it was 
referred to C. vaginale in later years (Zinnemann and Turner 1963).  Finally, after two 
large taxonomic studies were published in 1980 which analyzed DNA-DNA 
hybridization and electron microscopy data, the bacteria were classified into a new genus 
and called Gardnerella (Greenwood 1983; Piot and Van Dyck 1983).   
 G. vaginalis cells are nonmotile and do not possess flagella, catalase, endospores 
or typical capsules (Catlin 1992).  Pyrosequencing of a strain isolated from a woman 
without signs of BV (G. vaginalis 5-1) found that the genome size was approximately 
1.65 MB.  Electron microscopy by Reyn et al. proved that G. vaginalis has a gram-
positive cell wall (Reyn, Birch-Andersen et al. 1966); however, the physiological state of 
the bacteria affects their morphology and staining reactions (personal observation).  The 
bacterial cells have an angular or palisade arrangement of cells and volutin granules form 
in G. vaginalis during growth in the presence of a fermentable compound, leading to 
polar granule observation during gram staining (Edmunds 1960).  G. vaginalis is beta-
hemolytic on media containing human or rabbit blood but not on sheep blood agar; this 
hemolysis is improved in anaerobic incubation (Edmunds 1960; Shaw, Forsyth et al. 
1981; Greenwood 1983; Lam and Birch 1991).  G. vaginalis produces a pore-forming 
cytolysin, called vaginolysin, which is specific to mammalian epithelial cells and has 
been hypothesized to be involved in the pathogenesis of BV (Gelber, Aguilar et al. 2008). 
 The most successful media for isolation of G. vaginalis possesses both differential 
and selective features.  The addition of human blood allows identification of beta-
hemolytic G. vaginalis from nonhemolytic colonies, semiselective medium containing 
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colistin or nalidixic acid, to which G. vaginalis is resistant, allows for identification of 
resistant vs. sensitive bacteria, and addition of 1% corn starch allows for identification of 
G. vaginalis by the hydrolytic clearing of the opaque starch (Goldberg and Washington 
II. 1976; Mickelsen, McCarthy et al. 1977).  We have employed a combination of 
selective and differential media, containing nalidixic acid (30!g/ml), starch, and the pH 
indicator bromocresol purple.  The plates contain starch and when fermented by G. 
vaginalis, the pH indicator allows for selection of yellow colonies on a purple 
background.  Incubation of G. vaginalis at 37ºC for 24-48 hrs in an anaerobic box with 
10% CO2 produces adequate growth of this fastidious organism.   
 Electron microscopy revealed a fibrillar exterior layer (Figure 2) and ruthenium 
red staining indicates it has a polysaccharide component; however, this component is not 
capsular (Criswell, Stenback et al. 1972; Greenwood 1983).  Electron microscopy has 
also revealed pili radiating from the surface of G. vaginalis (Johnson and Davies 1984; 
Boustouller, Johnson et al. 1987).  The authors noted that clinical isolates displayed more 
heavily piliated cells and that laboratory strains quickly lost pili upon frequent subculture 
(Johnson and Davies 1984; Boustouller, Johnson et al. 1987).  Both the 
exopolysaccharide component and pili could be involved in G. vaginalis extraordinary 
ability to adhere to vaginal epithelial cells.  It has been shown that G. vaginalis cells 
adhere better to vaginal epithelial cells scraped from the vaginal wall than do L. 
acidophilus cells (Mardh, Holst et al. 1984).  Increasing acidity of the test medium also 
allowed for high adherence of G. vaginalis to vaginal epithelial cells (Sobel, Schneider et 
al. 1981).  Pretreatment of G. vaginalis with subinhibitory concentrations of  
Figure 2.  Electron micrograph of G. vaginalis.  Overnight G. vaginalis cultures 
grown in sBHI with 8% human serum were pelleted and washed with PBS, then 
negatively stained with phosphotungstic acid.  Electron microscopy revealed a 
fibrillar exterior layer indicated by the arrow. (Electronmicrograph courtesy of Dr. 
Michael Harwich, VCU) 
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metronidazole was able to significantly reduce the adherence of some of the strains tested 
(Peeters and Piot 1985).  Not only can G. vaginalis adhere to epithelial cells, it can 
hemagglutinate red blood cells; although, it seems that different adhesins are responsible 
for adherence to the two cell types (Scott and Smyth 1987).  Electron microscopy verified 
that adhesion to red blood cells occurred by means of pili, while adhesion to the epithelial 
cell line, McCoy, involved the outer fibrillar layer (Scott, Curran et al. 1989).   
 G. vaginalis is sensitive to ampicillin, which was originally used to treat BV; 
although, it is now treated with metronidazole or clindamycin, which have shown a 
higher degree of efficiency.  G. vaginalis is resistant to low levels of metronidazole; 
however, it is highly susceptible to the hydroxyl-metabolite of metronidazole (Easmon, 
Ison et al. 1982).  It is highly resistant to colistin, nalidixic acid, and amphotericin and 
can be resistant to tetracycline if the genome contains the TetM determinant, which is 
most often associated with a conjugative transposon located in streptococcal species 
(Huang, Gascoyne-Binzi et al. 1997).   
 Many animal models have been tested to analyze the role of G. vaginalis in BV; 
however a practical model is still lacking.  Intravenous inoculation of mice with viable G. 
vaginalis produced no effects (Boustouller, Johnson et al. 1986).  Different primate 
species were studied in an attempt to develop an animal model of BV infection; pigtailed 
macaques were colonized but no clue cells were found, tamarins and chimpanzees were 
not colonized, and grivet monkeys were able to be colonized with G. vaginalis, but only 
when a mixed culture of G. vaginalis and Mobiluncus were used to infection the monkey 
(Johnson, Ison et al. 1984; Mardh, Holst et al. 1984).  There has also been work to 
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develop an equine model; Gardnerella strains have been detected in the genital flora of 
mares, the first observation of natural infection in animals (Salmon, Walker et al. 1991). 
 The significance of G. vaginalis in BV is disputed.  However, approximately 95% 
of women suffering from BV are heavily colonized by G. vaginalis (Gardner and Dukes 
1955; Holst, Svensson et al. 1984; Borchardt, Adly et al. 1989).  The finding of a 
negative G. vaginalis culture had a 97% predictive value of exclusion of bacterial 
vaginosis (Amsel, Totten et al. 1983; Cristiano, Coffetti et al. 1989).  G. vaginalis has 
also been detected as the sole infecting species in other infection sites, including the 
bloodstream, urogenital tract of both men and women, the kidneys, and bone tissue; this 
points to the pathogenic potential of G.vaginalis (Piot, Van Dyck et al. 1984; Reimer and 
Reller 1984; Reimer 1991; Amaya, Al-Dossary et al. 2002; Graham, Howes et al. 2009). 
In the laboratory, G. vaginalis is sensitive to phagocytosis and killing by 
neutrophils in the presence of human serum, in a process mediated by complement 
activated by the alternative pathway (Easmon, Clark et al. 1985).  However, it has been 
shown by Swidsinski et al. that G. vaginalis is able to form an adherent biofilm on the 
vaginal epithelium of women with BV (Swidsinski, Mendling et al. 2005).  The 
formation of this biofilm may interfere with the immune response to G. vaginalis.  A 
follow-up paper observed the resurgence of a dense and active bacterial biofilm on the 
vaginal mucosa, consisting primarily of G. vaginalis, after treatment of BV with 
metronidazole (Swidsinski, Mendling et al. 2008).  They hypothesized that development 
of an adherent biofilm by G. vaginalis contributes to the pathogenesis and recurrence of 
BV (Swidsinski, Mendling et al. 2005).  Little is known about the G. vaginalis biofilms; 
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therefore, we sought to characterize the biofilm, and identify genes involved in formation 
of the biofilm.  
  
Biofilms 
 It has recently been recognized that planktonic cell growth does not accurately 
reflect bacterial growth in nature or in infectious diseases, where most bacteria grow as 
biofilms (O'Toole, Kaplan et al. 2000; Lindsay and von Holy 2006).  Biofilms are 
communities of microorganisms that are surrounded by an extracellular polymeric matrix 
composed of polysaccharides, proteins and/or nucleic acids, which promote intercellular 
adhesion and adhesion to surfaces.  Examples of microorganisms that utilize primarily 
polysaccharide components in their biofilm matrix include S. aureus which utilizes poly-
N-acetylglucosamine or PNAG (O'Gara 2007) and P. aeruginosa which utilizes alginate 
(Ryder, Byrd et al. 2007).  Examples of microorganisms that utilize primarily protein 
components in their biofilm matrix include Acinetobacter baumannii which utilizes a 
biofilm-associated protein or BAP (Loehfelm, Luke et al. 2008) and Bacillus subtilis 
which utilizes a polysaccharide and the protein TasA (Chai, Chu et al. 2008).  The final 
type of biofilm matrix is a nucleic acid based matrix, normally composed of extracellular 
DNA (eDNA).  Examples of microorganisms that utilize eDNA in their biofilm matrix 
include Listeria monocytogenes (Harmsen, Lappann et al. 2010) and Bacillus cereus 
(Vilain, Pretorius et al. 2009).  These matrix components are not mutually exclusive; 
organisms able to utilize a combination of matrix components are quite common.  
Salmonella sp. are able to use curli, cellulose, and the biofilm-associated protein BapA to 
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form a biofilm (Jonas, Tomenius et al. 2007).  Enterococcus faecalis, which produces a 
biofilm-associated protein Esp, also has been found to promote autolysis of its own cells 
to release  eDNA which plays a role in biofilm formation by the organism (Thomas, 
Thurlow et al. 2008).  Not only is there considerable variation in biofilm structure 
between different bacterial species, but a single species may also produce biofilms that 
vary considerably in matrix composition depending on environmental conditions.  An 
example of this is Staphylococcus epidermidis, in which Hennig et al. described a 
spontaneous switch from biofilm formation mediated by polysaccharides to biofilm 
formation mediated by proteins in an icaC insertion mutant (Hennig, Nyunt Wai et al. 
2007). 
 The biofilm mode of growth imparts on its constituent bacteria resistance to 
antimicrobial agents (Passerini de Rossi, Garcia et al. 2009), disinfectants (Kim, Ryu et 
al. 2007), drying (Vanderlinde, Harrison et al. 2009), ultraviolet light (Bak, Ladefoged et 
al. 2009), acid exposure (Kubota, Senda et al. 2009), phagocytosis (Cerca, Jefferson et al. 
2006) and sheer stress (Giao, Azevedo et al. 2008).  This resistant phenotype of biofilms 
is due to many factors including:  restricted penetration of antibiotics/disinfectants, 
production of antimicrobial destroying enzymes, altered growth rate of some cells, and 
overexpression of stress response genes (del Pozo and Patel 2007).   
 Biofilm development requires a series of complex but distinct and well-regulated 
steps.  The exact molecular mechanisms differ from organism to organism, but the stages 
are similar across a wide range of microorganisms.  The steps of biofilm development 
are:  (1) microbial attachment to a surface, (2) intercellular attachment and aggregation of 
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bacterial cells, (3) biofilm maturation, and (4) dispersal of bacterial cells for production 
of new biofilms (Figure 3).  Many environmental cues can stimulate or repress biofilm 
formation.  For example, changes in salt concentration affect biofilm formation by the 
water pathogen Vibrio cholera, leading to an increase in bacterial mobility and increased 
infection rate during dry or flood conditions (Shikuma and Yildiz 2009).  Examples of 
other environmental cues that can affect biofilm formation are low temperature, which 
increases expression of biofilms in E. coli and Y. pestis (Perry, Bobrov et al. 2004; 
White-Ziegler, Um et al. 2008), and growth in non-optimal growth conditions, which 
increases biofilm formation in environmental isolates of E. coli (Castonguay, van der 
Schaaf et al. 2006).   
 A well characterized biofilm whose development has been extensively researched, 
is the formation of a biofilm on the surface of a subvenous catheter.  When inserting the 
catheter into the bloodstream, bacteria become attached to the tip and length of the 
catheter surface.  Rapidly, blood plasma proteins, platelets, fibrin and leukocytes bind to 
the surface of the catheter; these host products serve as scaffolding for the developing 
biofilm and receptors for newly arriving bacteria (Cappelli, Tetta et al. 2005).  S. aureus 
adheres to proteins like fibrinogen and fibronectin found on the catheter in the first step 
of biofilm development (Arciola, Campoccia et al. 2005; O'Neill, Humphreys et al. 
2009).   
Once bacteria are attached to the surface of the catheter, phenotypic changes in 
the bacteria alters protein expression to further produce adhesins that anchor the bacterial 
cells to each other and to the catheter surface (Vandecasteele, Peetermans et al. 2003).  S.  
Figure 3.  Steps of biofilm development.  (1) Attachment:  Cells affix to 
substratum using surface proteins like MSCRAMMs and surface induced gene 
expression results in a protein profile significantly different from planktonic 
bacteria, (2)  Aggregation:  Cells orient themselves using surface proteins like 
Biofilm-associated proteins (BAPs), allowing for development of clusters and 
motility is lost, (3) Maturation:  Cell communication (potentially through 
quorum sensing) leads to cell clusters reaching maximum thickness via 
production of exopolysaccharide, (4) Dispersal:  Production of enzymes to 
disperse bacteria or in some bacteria, the protein profile begins to resume that of 
planktonic bacteria allowing for the dispersal of bacteria from the biofilm.  
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aureus bovine mastitis isolates produce a biofilm-associated protein called Bap that acts 
as an intercellular adhesion, anchoring bacteria to each other and causing maturation of 
the biofilm (Cucarella, Solano et al. 2001).  As the bacterial cells multiply, they can 
produce exopolysaccharides or “slime” which leads to differentiation into true biofilms:  
exopolysaccharide-encased bacterial communities resistant to many negative 
environmental stimuli (Costerton, Stewart et al. 1999).  Furthermore, just as there are 
environmental cues for events leading to biofilm development, there are cues which lead 
to maturation of the biofilm.  Many bacteria utilize a communication system that employs 
“messengers” produced by individual bacterial cells; when these signals accumulate to a 
certain density they cause the expression of specific sets of genes, including genes 
involved in biofilm formation.  An example of this communication system is quorum 
sensing in gram negative bacteria which utilize acylhomoserine lactone signals to talk 
between bacteria (Fuqua, Winans et al. 1994). 
Finally, in order to colonize new surfaces the bacteria within the biofilm must 
detach and disseminate.  Dispersal is accomplished by shearing, where pieces of the 
biofilm can break off in the flow of blood or urine and colonize new surfaces, or by 
enzymatic dispersal.  An example of enzymatic dispersal is seen in P. aeruginosa, which 
produces an enzyme called alginate lyase that is able to digest the polysaccharide 
component of its biofilm, releasing bacteria into the environment (Boyd and Chakrabarty 
1994). 
The medical community has gradually recognized biofilms as important aspects 
of disease, especially in patients with indwelling medical devices or who are 
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immunocompromised (Lindsay and von Holy 2006).  The biofilm phenotype is 
associated with chronic, indolent, and relapsing infections.  Examples of widely studied 
and well-recognized biofilms include those found in dental plaque, catheter infections, 
pulmonary infections, and endocarditis.  Most biofilm diseases are treated by antibiotic 
therapy and removal of the infected device (i.e. catheter, heart valve, artificial joint).  
Extended administration of antibiotics may be required and even prolonged therapy may 
not be effective. Device removal is not cost-effective and may extend the patient’s 
recovery period; therefore, more effective therapies, like biofilm-dispersing enzymes are 
being developed.   An important step in understanding the pathogenesis of BV would be 
characterization of biofilm formation in G. vaginalis.  Identification and characterization 
of the gene responsible for biofilm formation in Gardnerella could lead to novel 
treatment modalities and an improved understanding of this inadequately described 
condition. 
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Chapter 2 
Materials and Methods 
 
BV-associated strains and culture conditions.  All media components were from Becton 
Dickinson unless otherwise noted (BD, Franklin-Lakes, NJ).  BV-associated bacterial 
species used in this study, references to their association with BV, and the source of the 
strains are listed in Table 1.  The bacterial strains used in this study were purchased from 
ATCC or isolated from confirmed cases of BV (confirmed by Amsel criteria and Nugent 
score) at Brigham and Women’s Hospital, Boston, MA (Onderdonk, Lee et al. 2003), or 
isolated as part of this study from Virginia Commonwealth University Women’s Health 
Clinic.  Strains from the VCU Women’s Health Clinic were isolated from vaginal swab 
specimens from women diagnosed with BV by the Amsel criteria (Holmes, Spiegel et al. 
1981).  Individual colonies were isolated from Brucella Blood agar (Oxyrase, Mansfield, 
OH) and cultured in supplemented Brain Heart Infusion broth (sBHI); Brain Heart Infusion 
broth (Difco) containing 2% (w/v) gelatin, 0.5% yeast extract, 0.1% starch, and 0.1% 
glucose. All cultures were grown under anaerobic conditions, in approximately 10% CO2 
with the use of the AnaeroPack system (Mitsubishi Gas Chemical Co, Tokyo, Japan).  For 
some experiments, cultures were grown in sBHI supplemented with 1% glucose (sBHIG), 
sBHI supplemented with 8% heat-inactivated human serum (sBHIs), or in standard BHI or 
BHIG. 
Table 1.  BV-associated bacterial species used in this study. 
Organism 
Strain 
and 
source Reference to involvement in BV 
Gardnerella 
vaginalis 
5-1*, 
465*, 
101-1!, 
49145" 
Menard et al. (2008), Oakley et al. 
(2008), Fredricks et al. (2005), 
Marrazzo et al. (2008) 
Atopobium 
vaginae 
FA! Menard et al. (2008), Oakley et al. 
(2008), Fredricks et al. (2005), 
Marrazzo et al. (2008) 
Zhou et al. (2004) 
Mobiluncus mulieris BV 26-9! Menard et al. (2008), Oakley et al. 
(2008), Fredricks et al. (2005), 
Marrazzo et al. (2008) 
Prevotella bivia 29303", 
715BVD! 
Oakely et al. (2008), Fredricks et al. 
(2005) 
Veillonella sp. 715BVA! Oakley et al. (2008), Lefevre et al. 
(1985), Biagi et al. (2009) 
Peptostreptococcus 
sp. 
715BVC! Oakley et al. (2008), Marrazzo et al. 
(2008) 
Peptoniphilus sp. 718BVA! Fredricks et al. (2005), Marrazzo et 
al. (2008) 
Fusobacterium 
nucleatum 
718BVC! Oakley et al. (2008) 
* Brigham and Women’s Hospital. 
! VCU Women’s Health Clinic. 
" American Type Culture Collection. 
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16s Polymerase Chain Reaction (PCR) and identification of BV-associated anaerobes.  
Genomic DNA was isolated from cultured BV-associated anaerobes from patients from the 
VCU Women’s Health Clinic using the DNeasy Blood and Tissue kit (Qiagen, Valencia, 
CA) and amplified by PCR using universal primers for the 16S rRNA gene found in Table 
2.   PCR reactions were performed in a TC-312 thermocycler (Techne, Staffordshire, UK).  
PCR reaction mixtures consisted of 25 !l HiFi PCR Mix (Invitrogen, Carlsbad, CA) and 4 
mM primers.   
Conditions for PCR were as follows, one initial cycle at 94ºC for 2 minutes 
followed by 35 cycles of:  94ºC 30 seconds to denature, 50ºC 30 seconds to hybridize, and 
71ºC 30 seconds for extension.  A final extension at 72ºC for 5 min after the final cycle 
and the reactions were chilled to 4ºC.  PCR products were sequenced at the VCU Nucleic 
Acids Core Facility under the supervision of Dr. Gregory Buck and species were identified 
by a 98% or greater identity to sequences in the NCBI database using BLASTn.   
 
Non-BV related strains, culture conditions and plasmids used.  E. coli was grown 
aerobically in Luria-Bertani broth (LB) and on LB agar with appropriate antibiotics at the 
following concentrations:  ampicillin 100 !g/ml and chloramphenicol 35 !g/ml.  S. aureus 
cultures were grown aerobically in TSB broth at 37ºC with appropriate antibiotics at the 
following concentrations:  chloramphenicol 10 !g/ml and erythromycin 10 !g/ml.   L. 
lactis cultures were grown aerobically in GM-17 broth at 30ºC (LB, TSB and GM-17 
media from Sigma-Alderich, St. Louis, MS).  Plasmids used are seen in Table 3. 
 
Table 2.  Primers used in this study. 
Primer Label Sequence 
UnivFWD 5’-AGAGTTTGATCCTGGCTCAG-3’  
UnivREV 5’-GGACTACCAGGGTATCTAAT-3’ 
AP1 5’-GTAATACGACTCACTATAGGGC-3’ 
AP2 5’-ACTATAGGGCACGCGTGGT-3’ 
GSP1 5’-TCTGACGAATTGGTTATATTCGCATC-3’ 
GSP2 5’-CAACAAGTTCACGACACCACTTATTG-3’ 
BapEpiIntein3 5’-GTGTGGTTGCTCTTCCGCAACCTACA-3’ 
BapEpiRev3 5’-GTGTGGCATATGGATATTGCAAATAA-3’ 
BapSbfFWD 5’GGTTGGCCTGCAGGCGTGATTAATTCATA
TACGAATAAATTAC-3’ 
BapSbfREV 5’GGTTGGcctgcaggTTAGTCGCGCTTCTTCC
TGCG-3’ 
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Non-BV Organisms Used Strain 
Escherichia coli CH3-Blue chemically competent bacteria 
(Bioline) 
BL21-CodonPlus (DE3)-RIL Competent 
bacteria (Stratagene) 
Lactococcus lactis ATCC 11454 
Staphylococcus aureus RN4220 
RN4220!ica (eyrthromycin 10 !g/ml) 
Plasmids Used Antibiotic Resistance 
pCR2.1®Topo E. coli, Ampicillin 100 !g/ml 
pCR3.2®Topo-bapL E. coli, Ampicillin 100 !g/ml 
pKYB1 E. coli, Kanamycin 50 !g/ml 
pKYB1-bapL E. coli, Kanamycin 50 !g/ml 
pRB473 E. coli, Chloramphenicol 35 !g/ml 
S. aureus, Chloramphenicol 10 !g/ml 
pRB473-bapL E. coli, Chloramphenicol 35 !g/ml 
S. aureus, Chloramphenicol 10 !g/ml 
Table 3.  Non-BV organisms and plasmids used in this study. 
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Agarose gels.  Agarose gels were prepared by dissolving agarose in 1X Tris-Acetate-
EDTA (TAE) buffer (Fisher Scientific, Pittsburgh, PA).  Ethidium bromide was added to 
0.15 !g/ml prior to pouring the gel.  Generally, PCR products were run on a 1.5% agarose 
gels and 10X BlueJuice gel loading buffer (Invitrogen) was added to PCR products to 
reach a 1X dye concentration.  Gels were run at 120 volts until the dye front had migrated 
roughly $ of the length of the gel and then visualized under UV light.  DNA size was 
measured against a % DNA ladder, which was made of 1/10 volume of HindIII digested % 
DNA (New England Biolabs, Ipswich, MA), 1/5 volume of 10X Blue Juice gel loading 
buffer and 7/10 volume of deionized, distilled sterile water.  
 
Gardnerella biofilm growth assay.  Gardnerella vaginalis strain ATCC 49145 (American 
Type Culture Collection, Manassas, VA) and strains 5-1 and 465-5 (kindly provided by Dr. 
Robin Ross, Boston, MA) were grown under anaerobic conditions, in ~10% CO2 using the 
AnaeroPack system (MGC, Tokyo, Japan).  96-well tissue culture plate assays were 
performed essentially as previously described to determine optimal growth conditions for 
biofilm formation (Christensen, Simpson et al. 1985).  G. vaginalis was grown in Corning 
Cell-Bind Plates (Corning, Corning, NY) in various media without or with 1% 
supplemental glucose (G) including Luria broth (LB, LBG), Tryptic Soy Broth (TSB, 
TSBG), Mueller-Hinton (MH, MHG), Brain Heart Infusion (BHI, BHIG), De Man Rogosa 
Sharpe (MRS, MRSG), and a chemically defined medium resembling vaginal secretions 
(CDM, CDMG) (Onderdonk, Lee et al. 2003).   
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Biofilm assay of BV-associated organisms.  Biofilms were grown using 96 well Corning 
Cell Bind Plates (Corning).  Overnight cultures of G. vaginalis or BV-associated anaerobes 
were diluted 1:10 with fresh sBHI and individual wells of a sterile, polystyrene 96 well 
tissue culture plate were inoculated with 0.2 ml of dilute culture.  The tissue culture plates 
were incubated for 24-72 hrs at 37 °C, under anaerobic conditions.  Growth was analyzed 
using a 96-well plate spectrophotometer with a 595nm filter (BioTek 800 Plate reader, 
Winooski, VT).  Spent medium was removed, wells were washed once with 200 µl 
phosphate buffered saline (PBS) to remove nonadherent bacteria, and the plates were air 
dried for 1 hr. Biofilms were stained with 200 µl of safranin for one min, wells were 
washed gently to remove the safranin, and the plates were air dried. After the biofilms 
were visually analyzed and imaged using a flatbed scanner, the safranin was solubilized 
with 200 µl of 33% (v/v) acetic acid per well.  For quantitative results, the solubilized 
safranin was analyzed at optical density of 562nm using the 96-well plate reader (BioTek).   
 
Cell line.  ME-180 cervical epithelial cells (ATCC) were cultured at 37ºC in 5% CO2 in 
McCoy’s 5A medium (Quality Biologic, Gaithersburg, MD) supplemented with 10% fetal 
bovine serum and 1IU ml
-1
 penicillin/streptomycin (MediaTech, Manassass, VA).  ME-180 
cervical epithelial cells were used in place of vaginal epithelial cells due to availability and 
cost effectiveness. 
 
Confocal microscopic adherence assay. ME-180 epithelial cells were seeded into 6-well 
tissue culture plates (Greiner Bio One, Monroe, NC) at a density of 1.5 X 10
5
 cells/well 
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and incubated for 72 hrs or until a monolayer of cells had formed. The growth medium was 
removed, the cell monolayer was washed twice with sterile PBS and stained with 2.5!l/ml 
per well of Vybrant DIL membrane stain (Invitrogen) for 30 min at 37 °C, 5% CO2.  
Following incubation, the monolayers were washed twice with sterile PBS to 
remove excess stain. Overnight cultures of the various bacterial species were standardized 
to an optical density of 600 nm (OD600nm) of 0.150 using a NanoDrop 1000 (Thermo 
Scientific, Waltham, MA), and 2 ml of each culture was centrifuged to collect the cells. 
Bacteria were washed twice with 1 ml of sterile PBS and stained with 5!l of BacLight 
green bacterial stain in 1ml PBS (Invitrogen).The bacterial cells were incubated in the dark 
for 30 min at 37 °C, washed twice with 1 ml of sterile PBS to remove excess stain. 1 X 107 
stained bacteria in 0.5 ml PBS were added per well containing ME-180 cells. The plates 
were centrifuged at 700 rpm (18 g) for 2 min to maximize contact between the bacteria and 
cells.  
Time course assays indicated that adherence of bacteria to ME-180 cells did not 
increase after 15 minutes of contact (data not shown); therefore, the plates were incubated 
covered for 15 min at 37°C, 5% CO2.  After 15 minutes of exposure to G. vaginalis at 
37°C the ME-180 cells began to exhibit cytopathogenic changes. G. vaginalis was 
therefore incubated at 10°C to prevent cytotoxicity; these conditions did not affect binding 
of any of the other species. Finally, the wells were washed vigorously twice with sterile 
PBS to remove nonadherent bacteria and the wells were analyzed by confocal microscopy 
using a muliphoton confocal scanning laser microscope (Zeiss LSM 510; Microscopy Core 
Facility, Neuroscience Department, VCU, Richmond, VA). 
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Adherence assays were repeated 3 times on separate days, with three fields of view 
assessed. Adherence scores were based on a qualitative scoring system ranging from (-) to 
(+++) where (-) denotes that no adherent bacteria were observed in any field of view on all 
days tested; (+/-) indicates that less than 25% of ME180 cells had bacteria attached in any 
field of view on 1 or 2 days, but it was not repeatable for all 3 experiments; (+) denotes 
that less than 25% of ME180 cells had bacteria attached in all fields of view on all days 
tested; (++) denotes that greater than or equal to 25% to less than 75% of ME180 cells had 
bacteria attached in all fields of view on all days tested; and (+++) denotes that greater than 
or equal to 75% to 100% of ME180 cells had bacteria attached in all fields of view on all 
days tested. 
 Adherence of G. vaginalis was also tested when bacteria had been pretreated with 
proteinase K.  Overnight G. vaginalis cultures were centrifuged and resuspsended in PBS, 
and subjected to 20 !l/ml of a 20 mg/ml stock of proteinase K (Qiagen), rocking at room 
temperature for 1 hour.  After an one hour incubation, the bacteria was collected and 
washed three times with 1 ml of sterile PBS to remove residual proteinase K.  The bacteria 
were then used for confocal adherence assays as described above. 
 
G. vaginalis bacteria vs. supernatant cytotoxicity assay.  Overnight cultures of G. 
vaginalis strain 5-1 were centrifuged to remove bacteria and supernatant removed and 
dialyzed against 0.1X PBS overnight.  ME-180 epithelial cells were seeded into a 6-well 
tissue culture plate at a density of 3.0 X 10
4 
cells per well.  After 72 hours, or when a 
monolayer of cells had formed, the media was removed, and approximately 1 X 10
6
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bacteria in PBS or dialyzed supernatant were added to individual wells.  The monolayers 
were analyzed for cytotoxicity by light microscopy every hour for 4 hours.   
Cytopathogenicity was scored from 0 to 5 where 0 denotes no difference between 
the experimental well and control; a 1 indicates that less than 25% of cells were rounded; a 
2 indicates that 25-50% of cells were rounded; a 3 denotes that greater than 50% of cells 
were rounded; a 4 indicates that greater than 50% of cells were rounded with partial 
disruption of the monolayer; and a 5 indicates complete disruption/absence of the 
monolayer. After the monolayers were analyzed for 4 hours and given a cytotoxicity score, 
the bacteria were removed by pipetting off the liquid from each well and microscopic 
images of each well were taken with an Olympus CK2 microscope (Olympus, Center 
Valley, PA). 
 
Trans-well cytotoxicity assay.   Overnight cultures of G. vaginalis strain 5-1 were collected 
and resuspended in 1X PBS.  ME-180 epithelial cells were seeded into a 6-well tissue 
culture plate at a density of 3.0 X 10
4
 cells per well.  To assess the contact dependence of 
G. vaginalis-associated cytotoxicity, the media from the confluent 6-cell tissue culture 
plate was replaced with 2ml of 1X PBS, a sterile transwell with pores of either 0.45 µM or 
8 µM was inserted into a well, and 1.5 ml of the bacterial suspension was added to the top 
portion of the transwell. The monolayers were monitored every hour by light microscopy 
for cytopathogenic changes, such as cell rounding, loss of adhesion, and disruption of the 
monolayer.  Cytopathogenicity was scored using the scoring system described above and 
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microscopic images of each well were taken with an Olympus CK2 microscope at 
magnifications of 100X and 400X (Olympus).   
 
BV-associated anaerobe cytotoxicity assay. ME-180 epithelial cells were seeded into a 96-
well tissue culture plate at a density of 3.0 X 10
4
 cells per well. After 72 hours, or when a 
monolayer of cells had formed, the media was removed, and approximately 1 X 10
6
 
bacteria in PBS were added to individual wells. The monolayers were analyzed for 
cytotoxicity by light microscopy every hour for 4 hours. Cytopathogenicity was scored 
using the scoring system described above and microscopic images of each well were taken 
with an Olympus CK2 microscope (Olympus). 
 
Biochemical characterization of G. vaginalis biofilm matrix.  For biofilm cultures, G. 
vaginalis strain ATCC 49145 was grown anaerobically in BHI in T75 tissue culture flasks 
(Corning). Planktonic cultures were grown in BHI with shaking. Media was removed from 
biofilms; planktonic bacteria were collected by centrifugation and were washed once with 
double-distilled water. Loosely associated surface material was extracted by the vigorous 
resuspension of bacteria in distilled, deionized water, for a final cell density of 10
9
 
CFU/mL, as estimated by optical density at 650 nm (OD650). Protein concentrations in the 
extracts were determined with the use of Coomassie Protein Assay Reagent and the 
Bradford assay (Pierce Biotechnology, Rockford, IL). Nucleic acid content was estimated 
by measuring the optical density at 260 nm (OD260). Hexosamine contents were estimated 
by standard phenol-sulfuric acid assay with the use of glucose dilutions as standards 
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(Dubois, Gilles et al. 1951) . Three separate experiments were performed, and statistical 
significance was determined with the Student t test. 
 
Bradford assay for protein concentration.  Protein concentrations were determined by 
performing a Bradford assay on known concentrations of bovine gamma globulin (Pierce 
Biotechnology) to generate a standard curve.  This standard curve was applied to 
measurements taken from dilutions of sample protein.  20 !l of protein sample was added 
to 200 !l of Coomassie Protein Reagent (Pierce Biotechnology) and vortexed for 20 
seconds.  The absorbance at 595 nm was then measured on a NanoDrop 1000 
spectrophotometer (Thermo Scientific) three times for each sample as well as each 
standard.  The average was then used to generate the standard curve and determine protein 
concentration.   
 
Lectin blots of G. vaginalis matrix material.  For lectin blots, 100 µL of the cellular 
extracts of G. vaginalis were diluted serially 5-fold in PBS and dilutions were blotted onto 
nitrocellulose with a vacuum manifold and probed with peroxidase-conjugated lectins: 
wheat germ agglutinin (WGA), concanavalin A, and Glycine Max (Sigma), as described 
previously (Jefferson and Cerca 2006). The blots were developed with the use of the ECL-
Plus Western blotting detection system (GE Healthcare, Piscataway, NJ). 
 
Confocal microscopy of G. vaginalis biofilms.  Strain 49145 was grown in BHIG in 35-mm 
collagen-coated glass-bottom dishes (MatTek, Ashland, MA) at 37°C anaerobically for 48 
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hours. Biofilms were stained with 3 µL SYTO 9 and 3 µL Alexa Fluor 633-conjugated 
WGA (Invitrogen) in 3 mL phosphate-buffered saline solution for 15 minutes with 
rocking. Biofilms were washed twice with PBS solution, and confocal imaging was 
performed with a multiphoton confocal scanning laser microscope (Zeiss LSM 510; 
Microscopy Core Facility, Neuroscience Department, VCU, Richmond, VA). The 
objective was an Acroplan 63X/0.9W (Carl Zeiss Microimaging, Inc, Thornwood, NJ). 
The excitation wavelengths that were used were 488 nm and 633 nm; bandpass filters for 
emitted light were 500 nm to 530 nm and 650 nm.  
 
Biofilm degradation assays.  To analyze the dissolution of established biofilms, 24 hour-
old biofilms were subjected to 5-fold dilutions of various compounds in fresh BHIG (or in 
50 mM/L NaOAc; pH 4.2 for sodium metaperiodate).  Stock solutions were 20 mg 
proteinase K/mL (Qiagen), 20 mg trypsin/mL, 5U chitinase/mL, 30% H2O2, 10 M/L lactic 
acid, 20% sodium dodecyl sulfate (SDS), 4 mg sodium metaperiodate/mL in 50 mM/L 
sodium acetate pH 4.2, and 25 U deoxyribonuclease (DNasel)/mL (Ambion, Austin, TX).  
Biofilms were incubated for 20 hours, the media was removed, and the biofilms were 
washed with PBS solution, dried, and stained with safranin.  Digital images of the biofilms 
were taken by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-
Packard Company, Palo Alto, CA). 
 
Luciferase assay for bacterial viability.  The BacTiter luciferase assay for adenosine 
triphosphate (Promega Corp, Madison, WI) was used to determine bacterial viability. To 
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correlate viability with relative light units, planktonic cultures and biofilm cultures that had 
been resuspended by pipetting up and down were diluted serially 10-fold in BHI.  10 µL of 
each dilution was plated on BHI agar. The plates were incubated anaerobically for 72 
hours, and colony forming units (CFUs) were determined, and 200 µL of each serial 
dilution was placed in Cell Bind–coated 96-well clear bottom black plates (Corning).  
Cells were collected by centrifuging the plates, and the media were replaced with 50 µL 
BacTiter reagent (Promega).   After 10 minutes at 21°C, luminescence was analyzed with a 
Tropix luminometer (GE Healthcare, Piscataway, NJ) for 1 second. 
 
Planktonic and biofilm culture sensitivity assays.  For sensitivity assays, 200 mM 
hydrogen peroxide and 2 M lactic acid (Sigma) were diluted 2-fold in BHI or CDM and 
added to G. vaginalis biofilm and planktonic cultures. Plates were incubated anaerobically 
for 20 hours at 37°C; cells were collected by centrifugation, resuspended in 50 µL BacTiter 
reagent (Promega), and transferred to black 96-well plates (BD Falcon).  Viability was 
assessed as described earlier for the luciferase asay. The concentration of H2O2 or lactic 
acid that was required to bring about a 90% decrease in relative light units was recorded as 
the MBC90 for each chemical. 
 
Proteinase K-treated biofilm sensitivity assays.  The effect of treating biofilms with 100 µg 
proteinase K/mL for 24 hours on viability was determined with the BacTiter assay, as 
described earlier. For proteinase K–treated biofilm sensitivity assays, the media in the 
wells was replaced with BHIG that contained 100 µg of proteinase K/mL. The biofilms 
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were preincubated with the protease for 1 hour; sensitivity to H2O2 and lactic acid was 
determined as described earlier.  For a Proteinase K time course, biofilms were stained 
using Live/Dead BacLight stain, 100 µg of proteinase K/mL was added to a G. vaginalis 
biofilm, and confocal images of the same field of view were collected every 20 minutes for 
280 minutes.  Red color indicates live bacteria, while green color indicates dead bacteria. 
 
Degradation assay with natural proteases.  To analyze the dissolution of established 
biofilms by natural proteases, 24 hour-old biofilms were subjected to 5-fold dilutions of 
various enzymes in fresh PBS at pH 4.5 or 7.4.  Stock solutions were 10 U Bromelain, 10 
U Papain, 5.78 U Ficin, and 345 U Pepsin.   Biofilms were incubated for 20 hours, the 
media was removed, and the biofilms were washed with PBS, dried, and stained with 
safranin.  Digital images of the biofilms were scanned using an HP color LaserJet 2820 
printer (Hewlett Packard Company).  The safranin stained biofilms were solublized with 
200 µl of 33% (v/v) acetic acid per well.  For quantitative results, the solubilized safranin 
was analyzed at optical density of 562nm using a 96-well plate reader (BioTek).  Technical 
replicates and biologic replicates were performed on each strain and the absorbance 
readings were averaged.  These averaged absorbance readings were compared to control to 
give a percent reduction in biofilm mass. 
 
Antibiotic sensitivity assay using natural proteases.  24 hour biofilms were grown in 96-
well plates in BHIG anaerobically at 37°C.  Planktonic cultures were grown in 50 ml 
conical tubes in BHIG with gentle shaking anaerobically at 37°C.  Media was removed 
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from biofilm wells and replaced with either 200 !l BHIG as control, 200 !l of 1.8375 
!g/ml clindamycin (3X MIC) in BHIG, 200 !l of 10 U papain in BHIG or 200 ul of 10 U 
papain containing 1.8375 !g/ml of clindamycin in BHIG.  These cultures were incubated 
anaerobically for 16 hours at 37°C.  Media was removed from another biofilm well and 
pretreated with 200 !l of 10 U papain in BHIG for 2 hours anaerobically at 37°C, media 
was removed and wells washed with 200 !l of sterile PBS and 200 !l of 1.8375 !g/ml 
clindamycin was added to the wells and incubated for 16 hours anaerobically at 37°C.  
After the 16 hour incubation, all bacteria were harvested by 3 pulses of a sonicator, 10-fold 
diluted in 200 !l of BHIG and drip plated for CFU.   
 
Identification of Biofilm-Associated Protein (BAP) in G. vaginalis.  A partial sequence of 
the G. vaginalis genome is available from the Gardnerella vaginalis Genome Project, 
Stanford Genome Technology Center, which is funded by the Ellison Medical Foundation.  
The amino acid sequence of the staphylococcal Bap protein was compared to the partial 
genome of G. vaginalis using blastP software.  Structural similarities between the two 
proteins were analyzed by the RADAR software (EMBEL-EBI).   
 
DNA extraction.   Genomic DNA was isolated from G. vaginalis strain 5-1 using a phenol-
chloroform extraction.  Briefly, 100 ml of culture was centrifuged at 4000 rpm (4ºC) for 15 
min to pellet the bacteria.  The pellet was resuspended with 10 ml of lysis buffer 
containing lysozyme (10 mM Tris HCl pH 8.0, 10 mM NaCl, 10 mM EDTA, 1% Triton 
X100 and 10 mg Lysozyme) and allowed to incubate at 37ºC for 1 hr.  100 !l of Proteinase 
K (20 ug/ml stock) was added to the mixture and allowed to incubate at 65ºC for 1 hr 
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(Qiagen).  10 ml of a 1:1 mixture of phenol:chloroform was added, mixed gently as not to 
shear the DNA, and centrifuged at 12000 rpm (4ºC) for 5 min.  The upper aqueous solution 
was removed to a clean tube and two chloroform washes were performed.  The DNA was 
precipitated by addition of one tenth the volume of 3M sodium acetate and 2 volumes of 
ice-cold 100% ethanol.  This was allowed to rest at -20C for at least 1 hr.  The DNA was 
collected by centrifugation at 12000 rpm (4ºC) for 1 hr.  The DNA was washed once with 
70% ethanol and allowed to air dry for 15 minutes before being resuspended with an 
appropriate volume of nuclease-free water. 
 
 
Genome walking.  The 5’ upstream region of the bapL locus of G. vaginalis was amplified 
using the genome walking technique.  Briefly, a Universal Genome Walker Kit (Clontech, 
Palo Alto, CA) was used to construct a number of adaptor ligated G. vaginalis DNA 
fragment libraries (Sung, Chantler et al. 2006).  These libraries were used as a template for 
PCR amplification using a gene specific primer (GSP1) and an adaptor specific primer 
provided by the genome walking kit (AP1) (see Table 2 for primer list).  These PCR 
products were then used as a template for a second nested PCR using an internal gene 
specific primer (GSP2) and an internal adaptor specific primer (AP2).  Both PCRs were 
performed using a DNA polymerase suitable for long distance PCR (Clontech).  A single 
band was excised from the gel, purified, and then sequenced using the nested adaptor 
specific primer to initiate sequencing. 
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Full G. vaginalis genome sequencing.  Sequencing was performed in the VCU Nucleic 
Acids Core Facility using Roche 454 technology (Roche, Branford, CT). One full run of 
GS FLX and one half run GS FLX XLR were done for strain 5-1 (coverage of ~175 X).  
Five micrograms of DNA was sequenced as per the standard Roche sequencing protocol.   
 
Production of pKYB1-bapL for expression of peptide fragment of BapL.  Forward and 
reverse primers were used to amplify an antigenic region in the BapL protein, which was 
chosen by in silico analysis using the EMBOSS:antigenic program (EMBOSS explorer).  
The primers also introduced Sap1 and Nde1 restriction sites at the ends of the 0.5 kb PCR 
product; this allowed for the production of an intein-chitin binding domain (CBD) tagged 
fusion peptide (Zhang, Gonzalez et al. 2001).  The forward primer used was BapEpiIntein3 
and the reverse primer used was BapEpiRev3 (Table 2).  The 0.5 kb PCR product was 
then digested with Sap1 and Nde1 using specific buffers and BSA per the manufacturer’s 
instructions (New England Biolabs).  After digestion, the PCR product was gel purified 
using the QIAquick Gel Extraction Kit (Qiagen) as described by the manufacturer.  The 
digested 0.5 kb PCR product was ligated into the linearized E. coli vector pKYB1 (kan
50
) 
using Ready-to-Go T4 DNA Ligase tubes (Amersham Biosciences, Piscataway, NJ) with 
an hour incubation at 16ºC.   
 
CH3 chemically competent E.coli transformation.  2 !l of purified plasmid DNA was 
added to 50 !l of CH3 blue chemically competent E. coli cells (Bioline, Taunton, MA).  
This mixture was incubated on ice for 10 minutes.  The tubes were then transferred to a 
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water bath at 42ºC for 30 seconds and immediately after the incubation, 250 !l of SOC 
media (2% (wt/vol) tryptone, 0.5% (wt/vol) yeast extract, 85.5 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 20mM glucose) was added to the tube and incubated for one hour at 37ºC with 
shaking.  Following this recovery period, the cells were plated on LB plates with 
appropriate antibiotic selection. 
 
Plasmid DNA purification and screening.  Plasmid mini-preps were prepared from 
individual E. coli transformants that were grown overnight in 5 ml of LB broth with 
appropriate antibiotic, using a QIAprep Spin Miniprep Kit (Qiagen), as described by the 
manufacturer.  Plasmids were screened for correct insert by digestion with Nde1 and Kpn1 
(Bioline).  Plasmids with correct insert sizes were sequenced to confirm insertion of the 
accurate antigenic region of BapL before being used to transform BL21-
CodonPlus®(DE3)-RIL E. coli cells (Stratagene, La Jolla, CA). 
 
Induction of recombinant BapL peptide.  The pKYB1-based construct expressing the 
antigenic peptide from BapL was introduced into BL21 CodonPlus®(DE3)-RIL E.coli 
cells by transformation (Stratagene).  Strains harboring this plasmid were grown in 6 liters 
of LB supplemented with kanamycin 50 !g/ml to an OD600 of 0.8 and then IPTG (Fisher) 
was added to 1mM to induce expression of the recombinant peptide.   
 
Purification of recombinant peptide.  After induction, cells were grown for 6.5 hours and 
harvested by centrifugation at 6,000 rpm at 4ºC for 15 minutes.  Cell pellets were 
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resuspended in Impact buffer (20 mM Tris, 0.4 M NaCl, 0.1% Triton X100 and 
Complete™ protease inhibitor cocktail (Roche Applied Science, Mannheim, Germany)).  
Bacteria were lysed sequentially with a Thermo IEC French pressure cell press (Thermo 
Scientific) with 750 p.s.i. 3 times per 25 ml of resuspended bacteria, followed by 
sonication with a 60 Sonic Dismembrator at 15 watts (RMS) for 20 seconds 6 times on ice 
with 20 seconds rest between each repetition (Fisher).  Cell lysates were centrifuged at 
20,000 rpm at 4ºC for 30 minutes and supernatants were collected, filtered through a 0.45 
!M filter, and run through a chitin column.  The lysate was loaded onto a column made of 
chitin beads (New England Biolabs); the flow-thru was collected and passed back over the 
column to ensure protein binding to the column.  The column was washed with 5 column 
volumes of cold, sterile Impact buffer, followed by 2 washes with 15 ml of Impact buffer 
and 1:1000 dilution of Triton X100.  Finally, the column was washed with 15 ml of Impact 
buffer containing 750 !l DTT, about 1 inch of liquid was left in the column and the 
column was sealed with parafilm and left overnight at 4ºC.  After the overnight incubation, 
the BapL peptide was eluted with the addition of 45 ml of Impact buffer.  The BapL 
peptide was concentrated, analyzed by SDS-PAGE using 4-12% Tris-glycine gels 
(Invitrogen) and protein concentrations were estimated by the Bradford method (Bradford 
1976).  Approximately 10 mg of purified recombinant peptide was submitted to Invitrogen 
for production of polyclonal rabbit antiserum by their standard protocols. 
 
Polyacrylamide Gel Electrophoresis.  Protein samples were analyzed using the NuPAGE 
protein system (Invitrogen) and were separated on pre-cast NuPAGE Novex Bis-Tris 4-
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12% gradient gels (Invitrogen).  4X NuPAGE LDS loading buffer was added to samples to 
achieve a 1X concentration and these samples were then boiled for 10 minutes prior to gel 
loading.  Gels were run in 1X MES SDS Running Buffer (Invitrogen), rinsed in deionized 
water three times for 5 minutes each and then stained in Imperial Protein Stain (Thermo 
Scientific) for 1-2 hours, followed by destaining in water overnight. 
 
Western blot analysis of BapL expression.  Samples for western blot analysis were 
prepared as follows.  Biofilm samples were grown for 48 hours in BHI or BHIG with 
media change after 24 hours.  Planktonic samples were grown for 24 hours in BHI with 
gentle shaking.  One BHIG biofilm was treated for 1 hr with 6 !l/ml of proteinase K (20 
!g/ml stock, Qiagen) to disrupt the biofilm and bacteria collected by centrifugation of the 
media.  Protein amount was standardized by pellet weight after centrifugation to collect the 
bacteria.  Proteins were extracted from the samples by resuspending with 1 ml of lysis 
buffer containing lysozyme and incubating for 45 minutes at room temperature with 
rocking.  Samples were centrifuged to collect the cell debris, supernatants collected, 
NuPAGE loading buffer added and samples boiled for 10 minutes.  Proteins were 
separated on NuPAGE Bis-Tris 4-12% gels as described.  Following electrophoresis, the 
polyacrylamide gel was rinsed in deionized water.  PVDF membrane was wetted in 100% 
methanol then incubated in transfer buffer.  Sponges were wetted in transfer buffer and 
used to surround the gel and membrane to ensure the system remained saturated with 
transfer buffer at all times.  The transfer was performed at 35 volts for 1 hour and 20 
minutes and later the membrane was incubated overnight in 1X PBS, 5% skim milk and 
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5% BSA (Difco, Franklin Lakes, NJ) at 4ºC.  The membrane was then incubated for 2 
hours at room temperature with shaking in a 1:1000 dilution of anti-BapL antibody in 1X 
PBS, 0.15% skim milk and 0.15% BSA.  The membrane was then washed 4 times for 10 
minutes each in 1X PBS, 0.05% Tween-20 (Fisher Scientific) followed by an incubation in 
a 1:10,000 dilution of goat anti-rabbit-HRP conjugate secondary antibody (Invitrogen) in 
1X PBS, 0.15% skim milk and 0.15% BSA for 1 hour at room temperature.  The 
membrane was washed four times for 10 minutes each in 1X PBS, 0.05% Tween-20.  The 
blot was incubated in ECL™ Plus chemiluminesce developing reagent (GE Healthcare).  
The blot was then wrapped in saran wrap, exposed to X-ray film, and developed in an X-
O-Mat.   
 
Reverse-transcriptase PCR.  The mRNA levels of G. vaginalis grown as a biofilm in BHI 
and BHIG and as a planktonic culture were analyzed for expression of bapL.  Overnight 
cultures of G. vaginalis strain 5-1 were diluted 1:25 in fresh BHI or BHIG in T75 flasks.  
The flasks were grown anaerobically for 48 hours with fresh media change after 24 hours.  
Biofilms were washed with deionized, distilled H20 to remove non-adherent cells and 
bacteria were collected by addition of 1ml ddH20 and scraping of cells from the surface.  
Planktonic cultures of G. vaginalis strain 5-1 were grown in 250 ml flasks of BHI 
anaerobically for 48 hours with gentle stirring to keep bacteria in the planktonic state.  All 
cultures were centrifuged to pellet the cells and RNA from both planktonic and biofilm 
cultures were extracted using a Fastpro RNA kit (MP Biomedicals, Solon. OH).  Isolated 
RNA was DNase treated to ensure the absence of genomic DNA contamination.  RNA was 
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converted to cDNA using bapL and G. vaginalis 16S reverse primers along with 
Accuscript reverse transcriptase (Stratagene, La Jolla, CA).  Syber green PCR reagent 
containing MgCl2, dNTPs and Taq polymerase was combined with cDNA and either bapL 
or 16S specific primers (Quantace, Norwood, MA).  Amplification was carried out using a 
thermocycle profile that included:  stage 1, 95ºC for 3 minutes; stage 2 consisting of 40 
cycles of 95ºC for 15 seconds, 61.5ºC for 15 seconds, 72ºC for 15 seconds; and stage 3 
consisting of 81 cycles of 55ºC for 15 seconds. 
 The absolute Ct values from 3 qPCR assays were averaged to determine the cycle 
threshold value from each sample.  Expression of bapL was normalized to 16S rRNA as 
determined by cycle threshold values using the following equation:  E=2^(16S Ct – bapL 
Ct).   
 
Immuno-fluorescence microscopy.  Cultures of G. vaginalis and L. lactis were grown 
overnight as previously stated, and diluted to an equal OD600 to ensure equal numbers of 
bacteria.  1 ml of each diluted culture was centrifuged to pellet the bacteria and washed 
two times by resuspending with 1 ml of sterile 1X PBS.  After washing, the pellets were 
resuspended with 1 ml of sterile 1X PBS, sonicated with 1 second pulses eight times to 
ensure the bacteria were not clumped, then a 1:10 dilution of BapL specific polyclonal 
rabbit serum was added to each tube and incubated at 37ºC for 30 minutes.  After the 
incubation, both bacteria were washed three times with sterile 1X PBS and then a 1:100 
dilution of Alexa-488 labeled goat-anti rabbit antibody was added to the tubes and 
incubated at room temperature in the dark for 30 min.  The bacteria were washed an 
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additional three times, resuspended with 1 ml of PBS, sonicated with 1 second pulses eight 
times, and a small volume was placed on a microscope slide and observed with an 
Olympus BX51 fluorescence microscope using a FITC filterset.  Both differential 
interference contrast (DIC) and fluorescence images were taken to localize the 
fluorescence staining to individual bacteria. 
 
Purification of anti –bapL IgG  antibodies.  BapL-specific IgG antibodies were purified 
from harvested rabbit serum by a ProPur Protein G Antibody Purification kit (NUNC™ 
Thermo Fisher Scienctific, Rochester, NY).  Briefly, 12 ml of filtered, harvested rabbit 
serum containing polyclonal antibodies against BapL were diluted 1:1 with binding buffer 
A, or 0.1 M sodium phosphate, 0.15 NaCl, pH 7.4.  The sample was then pipetted onto an 
equilibrated Protein G spin column and centrifuged at 150 g for 30 minutes.  The spin 
column was washed twice with 10 ml of binding buffer A to remove unbound 
contaminants.  Bound IgG was eluted with 10ml elution buffer B2, or 0.2M Glycine/HCl 
pH 2.5 directly into a fresh centrifuge tube containing 1.3 ml neutralization buffer C, or 1 
M Tris/HCl ph 9.0, to bring the pH of the sample to approximately 7.5.  The tube was 
swirled to ensure thorough mixing of the final eluate with neutralization buffer C.  The 
elution step was repeated, the samples pooled, and the antibody preparation was de-salted 
and concentrated using a 10 kDa MWCO ultrafiltration spinner that was supplied.  
Aliquots of 50 !l of purified BapL antibody were stored at -20ºC until further use. 
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Antibody inhibition assay of biofilm formation.  Overnight cultures of G. vaginalis were 
diluted 1:100 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator 
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody.  200 !l of 
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 24 hours.  
The wells were washed twice with sterile PBS to remove nonadherent bacteria and stained 
with safranin to assess biofilm formation.  Photographic images of the biofilm were taken 
by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-Packard 
Company).   
 
Antibody inhibition assay of initial adherence.  Overnight cultures of G. vaginalis were 
diluted 1:50 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator 
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody.  200 !l of 
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 2 hours.  
The wells were washed twice with sterile PBS to remove nonadherent bacteria and stained 
with safranin to assess biofilm formation.  Photographic images of the biofilm were taken 
by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-Packard 
Company).   
 
Antibody inhibition assay of aggregation.  Overnight cultures of G. vaginalis were 
standardized to ensure equal numbers of bacteria and either treated with PBS as a control, 
400 !g of anti-BapL antibody or 400 !g of preimmune antibody.  The OD600 of the 
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cultures was measured every 15 minutes for 120 minutes at room temperature and the 
measurements were plotted and slopes analyzed.   
 
Antibody inhibition assay of adherence to epithelial cells.  Overnight cultures of G. 
vaginalis were incubated for 30 minutes at room temperature on a rotator with either 400 
!g of anti-BapL antibody or 400 !g of preimmune antibody, standardized via OD600 
measurements to ensure equal numbers of bacteria then added to 80% confluent 
monolayers of ME180 cervical epithelial cells.  The plates were centrifuged at 600 rpm for 
2 minutes to maximize interaction between the bacteria and epithelial cells and incubated 
at 37ºC for 15 minutes in 5% CO2.  After the incubation, the wells were washed twice with 
PBS to remove nonadherent bacteria then bacteria were harvested by addition of 5% 
saponin for 5 minutes.  The wells were diluted 10-fold in PBS and 10 !l of each dilution 
was plated on BPS agar plates and incubated for 48 hours.  Colony-forming units were 
counted and percentage of adherence measured using the equation: 
 % adherence = (Experimental CFU/ Control CFU) x 100 
 
Extracellular matrix (ECM) protein adherence assay.  Overnight cultures of G. vaginalis 
were diluted 1:10 in PBS and incubated for 30 minutes at room temperature on a rotator 
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody.  Immulon 
plates (Thermo Fisher Scientific) were pre-coated with the ECM proteins fibrinogen, 
fibronectin, hyaluronic acid, elastin, and collagen IV by diluting the ECM proteins in 100 
mM carbonate buffer to a final concentration of 20 !g/ml and adding 200 !l of each per 
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well and allowing the plate to incubate for 16 hours at 4ºC.  200 !l of each bacterial culture 
was added to the Immulon plate that had been previously immobilized with ECM proteins.  
The plates were centrifuged at 600 rpm for 2 minutes to maximize the interaction between 
the bacteria and ECM proteins then incubated at 37ºC for 10 minutes.  After the 10 minute 
incubation, the wells were washed twice with 200 !l of sterile PBS to remove nonadherent 
bacteria, plates dried and the wells were stained with 200 !l of safranin.  Photographic 
images of the biofilm were taken by an HP color LaserJet 2820 printer with scanning 
capabilities (Hewlett-Packard Company).   
 
Mucin adherence assay.  Overnight cultures of G. vaginalis were diluted 1:10 in PBS and 
incubated for 30 minutes at room temperature on a rotator with either 400 !g of anti-BapL 
antibody or 400 !g of preimmune antibody.  Immulon plates (Thermo Fisher Scientific) 
were pre-coated with porcine mucin (stock 5%) in 100 mM carbonate buffer to a final 
concentration of 20 !g/ml and 200 !l of the diluted mucin was added to each well and 
incubated for 16 hours at 4ºC.  200 !l of each bacterial culture was added to the Immulon 
plate that had been previously immobilized with porcine mucin.  The plate was centrifuged 
at 600 rpm for 2 minutes to maximize the interaction between the bacteria and porcine 
mucin then incubated at 37ºC for 10 minutes.  After the 10 minute incubation, the wells 
were washed twice with 200 !l of sterile PBS to remove nonadherent bacteria, plates dried 
and the wells were stained with 200 !l of safranin.  Photographic images of the biofilm 
were taken by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-
Packard Company). 
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Mucin Dot Blot.  A 5% and 1% porcine mucin solution in 1X PBS was dotted onto strips 
of nitrocellulose membrane.  The membranes were allowed to dry at room temperature for 
1 hour then incubated for 1 hour at room temperature in 1X PBS with 5% skim milk and 
5% BSA.  G. vaginalis surface proteins were extracted by pelleting an overnight culture of 
G. vaginalis, rinsing the cell pellet in PBS, then sonciating the pellet for 30 seconds three 
times on ice.  Supernatant was collected and protein amount analyzed by OD280 
measurements.  400 !g of G. vaginalis proteins were allowed to interact with the blocked 
membranes for 1 hour in 1X PBS, 0.05% Tween-20 (Fisher Scientific).  After incubation 
with the G. vaginalis protein, the membrane was then washed 4 times for 10 minutes each 
in 1X PBS, 0.05% Tween-20, followed by an incubation with 10 !g/ml of purified anti-
BapL antibody in 1XPBS, 0.05% Tween-20, 0.15% skim milk and 0.15% BSA for 1 hour.  
After the primary antibody, the membrane was washed as described above, and incubated 
with a 1:10,000 dilution of goat anti-rabbit-HRP conjugate secondary antibody 
(Invitrogen) in 1X PBS, 0.15% skim milk and 0.15% BSA for 45 minutes at room 
temperature.  The membrane was then washed four times for 10 minutes each in 1X PBS, 
0.05% Tween-20.  The blot was incubated in ECL™ Plus chemiluminesce developing 
reagent (GE Healthcare).  The blot was then wrapped in saran wrap, exposed to X-ray film, 
and developed in an X-O-Mat.   
 
Opsonophagocytosis assay.  White blood cells (WBC) were prepared from fresh human 
blood collected from a healthy adult volunteer.  25 ml was mixed with an equal volume of 
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dextran-heparin buffer and incubated at 37°C for 1 hr.  The upper layer containing the 
leukocytes was collected, the cells were pelleted by centrifugation, and hypotonic lysis of 
the remaining erythrocytes was accomplished by resuspsion of the cell pellet in ddH20.  
WBC were then washed three times and resuspended in RPMI buffer (Gibco).  A 
hemocytometer was used to give a final WBC count of 1.5 X 10
6
 WBC per 100 !l.  The G. 
vaginalis bacterial strains to be evaluated for phagocyte-dependent killing activity of the 
anti-BapL antibody were grown anaerobically overnight in BHIG on 0.1 mm glass beads 
to stimulate biofilm formation.  Biofilms on the glass beads were dispersed by sonication 
on ice for 10 seconds.  The complement source was 50 !l of baby rabbit serum diluted in 
RPMI buffer.   
 The opsonophagocytic assay was performed with 100 !l of leukocytes, 50 !l of 
either dispersed bacteria or biofilm beads, 50 !l of complement solution, and 50 !l of 1:20 
diluted anti-BapL antibody or preimmune antibody.  The reaction mixture was incubated 
on a rotor rack at room temperature for 90 min.  The tubes were sonicated for 10 sec and 
10-fold diluted in RPMI buffer and plated on BPS agar plates.  The percentage of killing 
was calculated by determining the ratio of CFU surviving in tubes with bacteria, 
leukocytes, complement and antibody to CFU surviving in control tubes.  The percent 
killing was compared between biofilm samples and dispersed biofilm samples. 
 
Sandwich western of ME180 proteins probed with G. vaginalis proteins.  Monolayers of 
ME180 cervical epithelial cells were grown in T75 flasks until 100% confluent.  Cells 
were harvested by trypsin digestion, centrifuged at 1000 rpm for 12 minutes to remove the 
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trypsin then resuspended in 1 ml of sterile PBS.  Proteins were extracted by the addition of 
200 !l of NuPAGE loading buffer and incubation for 10 minutes at room temperature 
while rocking.  ME180 cervcial epithelial cell proteins were separated on NuPAGE Bis-
Tris 4-12% gels as described earlier.  Following electrophoresis, the polyacrylamide gel 
was rinsed in deionized water.  PVDF membrane was wetted in 100% methanol then 
incubated in 1X transfer buffer (20X NuPAGE transfer buffer and 10% methanol).  
Sponges were wetted in transfer buffer and used to surround the gel and membrane to 
ensure the system remained saturated with transfer buffer at all times.  The transfer was 
performed at 35 volts for 1 hour and 20 minutes following which the membrane was 
incubated for 1 hour  in 1X PBS, 5% skim milk and 5% BSA (Difco, Franklin Lakes, NJ) 
at 4ºC.  The membrane was then incubated for 1 hour with 200 !g of G. vaginalis surface 
proteins.  G. vaginalis surface proteins were extracted by pelleting an overnight culture of 
G. vaginalis, rinsing the cell pellet in PBS, then sonciating the pellet for 30 seconds three 
times on ice.  Supernatant was collected and protein amount analyzed by OD280 
measurements.  After incubation with the G. vaginalis protein, the membrane was then 
washed 4 times for 10 minutes each in 1X PBS, 0.05% Tween-20 (Fisher Scientific) 
followed by an incubation with 10 !g/ml of purified anti-BapL antibody in 1XPBS, 0.05% 
Tween-20, 0.15% skim milk and 0.15% BSA for 1 hour.  After the primary antibody, the 
membrane was washed as described above, and incubated with a 1:10,000 dilution of goat 
anti-rabbit-HRP conjugate secondary antibody (Invitrogen) in 1X PBS, 0.15% skim milk 
and 0.15% BSA for 45 minutes at room temperature.  The membrane was then washed 
four times for 10 minutes each in 1X PBS, 0.05% Tween-20.  The blot was incubated in 
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ECL™ Plus chemiluminesce developing reagent (GE Healthcare).  The blot was then 
wrapped in saran wrap, exposed to X-ray film, and developed in an X-O-Mat.   
 
Immunoprecipitation of ME180 proteins that interact with BapL.  The buffer of purified 
anti-BapL antibody was exchanged and desalted using Econo-Pac 10DG columns from the 
Affi-Gel® Hz Immunoaffinity Kit (BioRad, Hercules, CA).  The desalted purified anti-
BapL antibody was then coupled to Affi-Gel Hz Hydrazide Gel using the Affi-Gel® Hz 
Immunoaffinity Kit (BioRad).  Briefly, that purified anti-BapL antibody was oxidized by 
adding one-tenth the volume of sodium periodate to the purified IgG sample.  This mixture 
was rotated end-over-end for 1 hour at room temperature.  The oxidized antibody was then 
desalted again as described previously.  The oxidized, desalted anti-BapL antibody was 
incubated end-over-end for 16 hours at room temperature with washed Affi-Gel Hz 
Hydrazide Gel.  After the coupling reaction was complete, the gel was washed with PBS 
0.5 M NaCl, pH 7.4.  10 mg of G. vaginalis protein and 10 mg of ME180 cervical 
epithelial cell protein was allowed to interact for 30 minutes at room temperature while 
rotating.  This mixture was added to the washed Affi-Gel Hz Hydrazide Gel and allowed to 
rotate for 2 hours at 4ºC.  The Affi-Gel Hz Hydrazide Gel was then placed into a column, 
washed 2 times with PBS 0.5 M NaCl pH 7.4 and 2 times with PBS 50 mM NaCl pH 7.4.  
Bound protein was eluted by addition of 10 ml of 0.2M Glycine/HCl pH 2.5 into a tube 
containing 1.3 ml 1M Tris/HCl pH 9.0 to neutralize the protein solution.  The protein was 
concentrated using a 3 kDa MWCO filtration spinner.  The protein was separated by SDS-
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PAGE and the gel was stained overnight with Imperial Protein stain (Thermo Scientific), 
following by destaining in water.  
 
Ethyl methanesulfonate (EMS) mutagenesis.  A kill curve using liquid EMS (Sigma, 
molecular weight 124.16) amounts of 10 !l, 50 !l, and 250 !l for 5 minutes, 15 minutes, 
30 minutes and 1 hr showed that 50 !l of EMS for 30 minutes produced approximately 
90% killing of G. vaginalis bacteria.  3 mls of an overnight culture of G. vaginalis was 
centrifuged to collect the cells.  The bacteria were washed once with sterile PBS and 
resuspended in 500 !l of sterile PBS.  50 !l of stock EMS compound was added to the 
bacteria and allowed to rock at 37°C for 30 minutes.  After the 30 minute incubation, the 
bacteria were rinsed four times with sterile BHIG.  The final resuspension was in 1 ml of 
BHIG; this was allowed to incubate for 24 hours anaerobically at 37°C.  An additional 5 
ml of sterile BHIG was added to the mutagenized bacteria after the 24 hour incubation; this 
was allowed to incubate for an additional 24 hours before being used for FACS analysis.  
EMS is highly toxic and appropriate precautions were used including a lab coat and eye 
protection.  EMS usage was in a chemical safety hood and all equipment that came into 
contact with EMS was rinsed in 1M NaOH for at least 24 hours before being disposed of 
appropriately. 
 
Fluorescence-activated cell sorting (FACS) staining and analysis.  A 48 hour EMS 
mutagenized culture of G. vaginalis was centrifuged to collect the cells.  The pellet was 
washed two times with sterile PBS and sonicated for 8 one second pulses to ensure the 
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bacteria were not clumped.  The bacteria were stained with a 1:10 dilution of anti-BapL 
antibody for 30 minutes at 37°C.  After this incubation, the bacteria were collected by 
centrifugation and washed two times with sterile PBS.  The bacteria were then stained with 
a 1:100 dilution of Alexa-488 labeled goat anti-rabbit secondary antibody in the dark at 
room temperature for 30 minutes.  After this incubation, the bacteria were collected by 
centrifugation and washed two times with sterile PBS, before being sonicated for 3 one 
second pulses.  These stained bacteria were then analyzed by FACS, gating on 
fluorescence intensity.  Individual bacterial cells with low fluorescence intensity, 
signifying a potential bapL mutant, were collected in wells of a 96-well plate.  After the 
FACS run, the 96-well plate harboring low fluorescent bacteria was incubated 
anaerobically at 37°C for 48 hours.  Wells with growth after the 48 hour incubation were 
collected and added to snap-cap tubes containing 5 ml of BHIG.  These tubes were allowed 
to incubate anaerobically at 37°C for 24 hours before the culture was analyzed for biofilm 
formation using the 96-well assay described previously. 
 
Long-Distance PCR of the bapL gene.  Long-distance PCR reactions were performed in a 
TC-312 Techne thermocycler (Techne).  Primers used were BapSbfFWD and BapSbfREV 
which incorporated Sbf1 restriction sites onto each end of the PCR product (Table 2).  
PCR reaction mixtures consisted of 2.5 mM dNTPs, 5X Phire Buffer, 100 pM forward and 
reverse primers, F-120S Phire Hot start polymerase (Finnzymes, Espoo, Finland), water 
and genomic DNA.   
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Conditions for PCR were as follows, one initial cycle at 94ºC for 2 minutes 
followed by 10 cycles of:  94ºC 30 seconds to denature, 52ºC 30 seconds to hybridize, and 
70ºC 10 minutes for extension.  Immediately following, there was a second step with 30 
cycles of:  94ºC 30 seconds to denature, 56ºC 30 seconds to hybridize, and 72ºC 10 
minutes for extension.  A final extension at 72ºC for 15 minutes after the final cycle and 
the reactions were chilled to 4ºC.  A two cycle protocol was used; cycle one utilized a 
lower annealing temperature to increased the number of bapL gene products that could be 
used for amplification, while cycle two utilized a higher annealing temperature that 
produced highly specific amplification of the bapL gene.  
 
Production of pRB473-bapL for heterologous expression.  The 9.1 kb bapL PCR product 
was gel purified using the QIAquick Gel Extraction Kit (Qiagen) as described by the 
manufacturer.  The resulting PCR product was subcloned into the plasmid pCR2.1®-Topo 
(Invitrogen) to construct the recombinant plasmid pCR2.1-Topo-bapL.  This plasmid was 
used to transform CH3 blue chemically competent E.coli cells (Bioline) and plated on LB 
ampicillin 100!g/ml plates.  The recombinant plasmid was purified from pooled colonies 
of E. coli and subjected to Sfb1 restriction digest using its specific buffer and BSA per the 
manufacturer’s instructions (New England Biolabs) to drop out the bapL PCR product.  
The digested bapL PCR product was ligated into the Pst1-linearized E. coli/S. aureus 
shuttle vector pRB473 (amp
100
/cm
10
) using Ready-to-Go T4 DNA Ligase tubes 
(Amersham Biosciences) with an hour incubation at 16ºC.  2 !l of purified plasmid DNA 
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was added to 50 !l of CH3 blue chemically competent E. coli cells and transformed as 
described above. 
 Plasmid mini-preps were prepared from individual E. coli transformants that were 
grown overnight in 5 ml of LB broth with ampicillin concentration of 100 !g/ml, using a 
QIAprep Spin Miniprep Kit (Qiagen), as described by the manufacturer.  Plasmids were 
screened for correct insert by digestion with Pst1 (New England Biolabs).  Plasmids with 
correct insert sizes were used to transform S. aureus RN4220. 
 
Production of electrocompetent S. aureus RN4220.  Electrocompetent S. aureus cells were 
prepared from cultures grown in TSB at 37ºC with shaking.  Cultures were grown to 
exponential phase (OD600= 0.5-0.8) and then incubated on ice for 10 minutes.  The cultures 
were collected by centrifugation for 15 minutes at 4,000 rpm at 4ºC.  Care was taken to 
ensure all subsequent steps were performed on ice.  The pellet was then washed three times 
with one tenth the volume of ice-cold sterile water.  The pellet was then washed one time 
with one fifth the volume of cold sterile 10% glycerol.  The pellet was then resuspended in 
one tenth the volume of ice-cold sterile 10% glycerol and incubated at room temperature 
for 15 minutes.  The culture was collected by centrifugation for 5 minutes at 4,000 rpm at 
4ºC, resuspended in 500 !l of ice-cold 10% glycerol, and aliquots (100 !l) were then 
stored at -80ºC until further use. 
 
Transformation of electrocompetent S. aureus.  Plasmid DNA isolated as described above 
was used to transform S. aureus RN220.  Plasmid DNA (5 !l) was added to 75 !l of 
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electrocompetent S. aureus and incubated on ice for 10 minutes.  The mixture was then 
transferred to an electroporation cuvette with a gap length of 0.1 cm and pulsed one time 
using the MicroPulser (BioRad) pre-set S. aureus setting Sta (1.8 kV, 2.5 msec, 25 !F).  
Following electroporation, 250 !l of LB broth was added immediately to the cuvette and 
this mixture was then transferred to an eppendorff tube.  The antibiotic to be used for 
selection was added at a subinhibitory concentration (chloramphenicol = 0.1 !g/ml) and 
the cells were incubated for 1 hour with shaking at 37ºC.  Aliquots (75 !l and 225 !l) were 
then spread on TSA supplemented with appropriate antibiotic selection and incubated at 
30ºC for 48 hours. 
 
S. aureus biofilm assay.  Biofilms were grown using 96 well Corning Cell Bind Plates 
(Corning).  Overnight cultures of S. aureus RN4220 with empty vector or pRB473-bapL or 
S. aureus RN4220!ica with empty vector or pRB473-bapL were diluted 1:10 in fresh 
media and individual wells of a sterile, polystyrene 96 well tissue culture plate were 
inoculated with 0.2 ml of dilute culture.  The tissue culture plates were incubated for 24-72 
hrs at 37 °C, under aerobic conditions.  Growth was analyzed using a 96-well plate 
spectrophotometer with a 595nm filter (BioTek 800 Plate reader, Winooski, VT).  Spent 
medium was removed, wells were washed with 200 µl once with phosphate buffered saline 
(PBS) to remove nonadherent bacteria, and the plates were air dried for 1 hr. Biofilms were 
stained with 200 µl of safranin for one min, wells were washed gently to remove the 
safranin, and the plates were imaged using a HP color LaserJet 2820 printer with scanning 
capabilities (Hewlett-Packard Company). 
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Poly-N-acetyl glucosamine (PNAG) blot.  Standardized amounts of overnight bacterial 
cultures were centrifuged to pellet the cells and resuspended in 250 !l of 0.5 M EDTA.  
The samples were boiled for 5 minutes then centrifuged to pellet cell debris.  The 
supernatant was transferred to a new tube, 20 !l of proteinase K was added then the sample 
was heated at 65ºC for 1 hour.  After the 1 hour incubation, the samples were boiled for 5 
minutes to inactivate the proteinase K.  The samples were sonicated for 3-5 seconds and 
dilutions made in 1X PBS.  A piece of nitrocellulose blotting membrane (BioTrace NT, 
Pall Corporation) was cut to fit inside the blot apparatus (7.5 cm wide by 11.5 cm long).  
The cover paper was removed from the nitrocellulose and the membrane was soaked in 50 
ml of 5% methanol for 1-2 minutes.  The nitrocellulose membrane was rinsed in 50 ml of 
1X PBS; the nitrocellulose membrane was placed within the blotting apparatus and care 
was used to ensure that the instrument gasket had produced a tight seal.  200 !l of stock or 
diluted PNAG samples were loaded into individual wells in the blotting apparatus and the 
machine was allowed to run for 10 minutes or until all sample have been soaked up by the 
membrane.  The membrane was removed carefully and allowed to dry overnight between 
pieces of kimwipe. 
   The dried nitrocellulose membrane was soaked in 25 ml of 5% bovine serum 
albumin (BSA) solution for 1 hour at room temperature on a rocker.  The membrane was 
probed with 15 ml of primary antibody solution containing 3 !l of goat anti-PNAG 
antibody (1:5000 dilution), 1 ml 5% BSA solution, and 14 ml of 1X PBS for 3 hours at 
room temperature on a rocker.  The membrane was washed 3X with 15 ml of 1X PBS for 4 
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minutes each.  After the wash steps, the membrane was probed with l5 ml of secondary 
antibody solution containing 1.5 !l of rabbit anti-goat-HRP labeled antibody (1:10,000 
dilution) and 15 ml of 1X PBS for 1 hour at room temperature on a rocker.  The membrane 
was again washed 3X with 15 ml of 1X PBS for 4 minutes each.  The blot was incubated 
in ECL™ Plus chemiluminesce developing reagent (GE Healthcare).  The blot was then 
wrapped in saran wrap, exposed to X-ray film, and developed in an X-O-Mat.   
 
Phage Transduction.  The generalized transducing phage 80& was used to create the allelic 
exchange mutation of ica in S. aureus RN4220.  A freezer stock of Sa113 !ica was 
inoculated onto TSA supplemented with erythromycin, and grown overnight at 37ºC.  A 
single colony was subcultured onto a new plate and allowed to grow overnight at 37ºC.  
All of the culture was removed from the plate and resupended in 0.5 ml of TSB in a small 
tube.  200 !l of this culture was added to 0.4% soft agar in a new tube, along with 5 !l of 
2M CaCl2 and either 75 !l of phage 80& or no phage.  This mixture was plated on TSA 
plates and monitored for lysis.   
 Following lysis, the soft agar was collected, centrifuged, and the supernatant was 
filter sterilized through a 0.45 !m filter.  Aliquots of this lysate, either 75 or 150 !l, were 
then mixed with 150 !l of recipient bacteria, or S. aureus RN4220, and 5 !l of 2M CaCl2.  
The mixture was incubated with shaking at 37ºC for exactly 20 minutes, 5 ml of 20mM 
sodium citrate was added, the culture was centrifuged to pellet the bacteria, the pellet 
washed twice with 20 mM sodium citrate, then incubated for 1 hour and 45 minutes in 500 
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!l of 20 mM sodium citrate.  Finally, the mixture was plated on TSA supplemented with 
erythromycin and sodium citrate and these plates were incubated for 48 hours at 37ºC.   
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CHAPTER 3 
 
Analysis of Virulence Potential of Gardnerella vaginalis 
 
 
 Introduction 
  Gardnerella vaginalis is present in up to 95% of cases of BV (Catlin 1992; 
Marrazzo, Thomas et al. 2008); however, with the advancement of molecular tools, it has 
been shown that the number and diversity of anaerobes associated with BV is high 
(Oakley, Fiedler et al. 2008).  One study found that pure cultures of G. vaginalis do not 
always cause BV and the organism can occur, albeit in low numbers, in healthy women 
(Gardner and Dukes 1955; Fredricks, Fiedler et al. 2007).  Together, these findings cast 
doubt on the role of G. vaginalis in the pathogenesis of BV.  Recently, the term functional 
equivalent pathogen/pathogroup (FEP) has been proposed for polymicrobial  infections in 
which no one species alone is capable of causing disease, but rather the synergistic effects 
of the consortium give rise to the pathophysiology (Dowd, Wolcott et al. 2008).  
Inarguably, the vagina is colonized by numerous anaerobic bacteria during BV, but 
whether the symptoms and the syndrome are a consequence of the multi-species 
consortium or whether there is a key species in each case that precipitates the disorder has 
been a matter of debate for decades.  A follow-up study to the report that G. vaginalis in 
pure culture did not reliably cause BV found that fresh cultures initiated the infection more 
frequently (Criswell, Ladwig et al. 1969).  This study may suggest that under conditions 
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that foster expression of virulence determinants, G. vaginalis may have greater pathogenic 
potential.  Furthermore, recent studies indicate that G. vaginalis is equipped with a number 
of virulence properties and consequently, the idea that it is the etiologic agent of BV is 
being revisited (Swidsinski, Mendling et al. 2005; Gelber, Aguilar et al. 2008).   
One such virulence determinant is the ability of G. vaginalis to form a biofilm.  
Swidsinski et al. showed that G. vaginalis was able to form an thick, tenacious biofilm on 
the vaginal epithelium of women with BV (Swidsinski, Mendling et al. 2005).  This 
biofilm incorporated other bacterial groups into its layers, suggesting that the biofilm may 
enable other anaerobes to colonize the vagina.  Not only could formation of a biofilm 
allow other anaerobes to colonize the vagina, but the biofilm phenotype allows its 
constituent bacteria to be resistant to many negative environmental stimuli.  This biofilm 
phenotype may explain the high rates of relapse seen with BV. 
G. vaginalis also produces the toxin vaginolysin, which is a member of the 
cholesterol-dependent family of pore-forming toxins that lyse human red blood cells and 
vaginal epithelial cells (Gelber, Aguilar et al. 2008).  Vaginolysin has been hypothesized to 
be involved in the pathogenesis of BV.  G. vaginalis can also adhere well to vaginal 
epithelial cells and attaches equally well to exfoliated vaginal epithelial cells and to tissue 
culture cells (Sobel, Schneider et al. 1981; Scott and Smyth 1987).  Finally, not only does 
G. vaginalis have numerous virulence factors that could contribute to the pathogenesis of 
BV, it has also been implicated as the sole etiologic agent of infections outside of the 
reproductive tract.  There have been reports of G. vaginalis as the causative agent of 
vertebral osteomyelitis and discitis, retinal vasculitis, acute hip arthritis, and bacteremia 
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(Lagace-Wiens, Ng et al. 2008; Graham, Howes et al. 2009; Neri, Salvolini et al. 2009; 
Sivadon-Tardy, Roux et al. 2009). 
 Many of the bacterial species associated with BV have evolved to exist only in 
humans and consequently a reliable animal model for BV does not exist.  This has stymied 
efforts to tease out the pathogenesis of BV, hence studies of the etiology of BV are 
lacking.  Reports of the frequency with which different species are isolated exist but point 
only to association and not cause.  For example, Atopobium vaginae is frequently isolated 
from BV and one study indicates its potential to induce an inflammatory response, but 
there has not been a demonstration that it is equipped with specific virulence factors 
(Libby, Pascal et al. 2008).  In an effort to begin to unravel this etiologic mystery, we 
designed a simple model to test adherence to vaginal epithelial cells and used established 
models to analyze biofilm forming capacity and cytotoxicity of G. vaginalis and a number 
of additional BV isolates including A. vaginae, Prevotella bivia, Mobiluncus mulieris, a 
Veillonella sp., a Peptostreptococcus sp., a Peptoniphilus sp., and Fusobacterium 
nucleatum (Verstraelen, Verhelst et al. 2004; Nikolaitchouk, Andersch et al. 2008; Oakley, 
Fiedler et al. 2008). 
 
Results 
Adherence of BV-associated anaerobes to cervical epithelial cells 
We analyzed the ability of G. vaginalis strains 5-1, 465, and 101-1 to bind to ME-
180 cervical epithelial cells.  Overnight cultures were standardized to ensure equal 
numbers of bacteria.  The bacteria were stained with a green fluorophore, and allowed to 
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interact with the monolayer of red fluorescent-labeled ME-180 cervical epithelial cells for 
15 minutes before washing to remove nonadherent bacteria.  Figure 4 shows 
representative confocal microscopic images of the G. vaginalis adherence assay.  All G. 
vaginalis strains tested exhibited considerable adherence.  We next analyzed the ability of 
BV isolates:  A. vaginae, M. mulieris, P. bivia, Veillonella, Peptostreptococcus, 
Peptoniphilus, and F. nucleatum (Table 1) to bind to ME-180 cervical epithelial cells.  
Figure 5 shows representative confocal microscopic images of red ME-180 cells and green 
BV-associated bacteria; G. vaginalis is shown as a positive control.  Both G. vaginalis and 
Peptoniphilus exhibited considerable adherence.  Peptoniphilus adhered more 
homogenously to the ME-180 cells whereas G. vaginalis, which is very aggregative, 
adhered as large clusters.  As shown in Figure 5, F. nucleatum and A. vaginae exhibited 
some adherence to the epithelial cells, although to a significantly lesser degree than G. 
vaginalis or Peptoniphilus.  M. mulieris, P. bivia strain 715BVD, P. bivia strain 29303 
(data not shown), Veillonella, and Peptostreptococcus were unable to adhere to the cervical 
epithelial cells under these conditions.  Table 4 lists the adherence scores for each species 
after the 15 minute incubation with the monolayer; the scores correlate with the confocal 
microscopy images.  Each experiment was repeated three times with similar results 
 
Figure 4.  Adherence of G. vaginalis to cervical epithelial cells.  Bacteria were 
grown in sBHIG anaerobically at 37 °C for 24 hrs.  Bacteria (green) were 
standardized to ensure equal numbers, added to vaginal epithelial cells (red) and 
incubated for 15 minutes before washing to remove nonadherent bacteria.  
Qualitative estimates of adherence were ascertained by confocal microscopy.  
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Figure 5.  Adherence of G. vaginalis and BV-associated anaerobes to cervical 
epithelial cells.  Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours.  
Bacteria (green) were standardized to ensure equal numbers, added to cervical 
epithelial cells (red) and incubated for 15 minutes before washing to remove 
nonadherent bacteria.  Qualitative estimates of adherence were ascertained by 
confocal microscopy.  P. bivia strain 29303 is not shown but did not exhibit 
adherence.   
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Table 4.  Adherence and Cytotoxicity scores for the BV-associated 
anaerobes. 
Strain Cytotoxicity score* Adherence score! 
PBS control 0 - 
G. vaginalis 5-1 5 +++ 
G. vaginalis 101-1 5 +++ 
G. vaginalis 465 5 +++ 
A. vaginae FA 0 ++ 
M. mulieris BV26-9 0 ± 
P. bivia 29303 0 ± 
P. bivia 715BVD 0 ± 
Veillonella sp. 715BVA 0 - 
Peptostreptococcus sp. 
715BVC 
0 - 
Peptoniphilus sp. 0 +++ 
F. nucleatum 718BVC 0 + 
Adherence and cytotoxicity scores of the bacterial strains.  Adherence 
scores ranged from (-), indicating no bacteria atdhered to the ME180 cells, to 
(+++), indicating many bacteria adhered to the ME180 cells.  Cytotoxicity 
scores ranged from 0, indicating no change, to 5, indicating complete lysis of 
the ME180 monolayer.  Experiments were repeated three times and produced 
similar results each time. 
69 
  70 
Cytotoxicity of G. vaginalis 
 G. vaginalis strains 5-1, 465, and 101-1 were tested for their ability to cause cell 
rounding and lysis of ME-180 cervical epithelial cells.  Equal numbers of each bacterial 
species were added to a confluent monolayer of ME-180 cervical epithelial cells.  
Cytotoxicity scores (Table 4) and microscopic images (Figure 6) of the monolayer were 
recorded after 4 hours.  All G. vaginalis strains tested were a 5 on the cytotoxicity scale, 
causing complete lysis of the monolayer within 4 hours.  Supernatant from a G. vaginalis 
culture was also tested for cytotoxicity; however, supernatant had no cytopathic effect on 
the cervical epithelial cells. 
 
Trans-well assay to elucidate contact dependence of G. vaginalis cytotoxicity 
 Other cholesterol-dependent cytolysins depend upon adherence to exert their 
activity (Madden, Ruiz et al. 2001).  To investigate whether G. vaginalis requires direct  
contact with cervical epithelial cells to exert its cytotoxic effects, we performed 
cytotoxicity assays as described above; however, the bacteria were separated from the 
cervical epithelial cell monolayers with trans-well filters with a pore size of either a 0.45 
!m or 8.0 !m.  The trans-well filter with a pore size of 0.45 !m prevents direct contact of 
the bacteria and monolayer but does allow proteins produced by G. vaginalis to interact 
with the monolayer; whereas, the trans-well filter with a pore size of 8.0 !m allows direct 
contact of the bacteria with the monolayer.  Cytotoxicity was observed when the 8.0 !m 
transwell was used but not when the 0.45 !m transwell separated the bacteria from the  
Figure 6.  Cytotoxic changes of cervical epithelial cell monolayers challenged 
with G. vaginalis strains.  Bacteria were grown in sBHIG anaerobically at 37ºC for 
24 hours, standardized to ensure equal numbers, added to cervical epithelial cells 
and incubated for 4 hours.  Light microscopy images were taken after the 4 hour 
incubation. (magnification 100x) 
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epithelial cells (Figure 7) suggesting that direct contact between the bacteria and 
monolayer is required for cytotoxicity. 
 
Cytotoxicity of the BV-associated anaerobes 
 The BV-associated anaerobes were tested for their ability to cause cell rounding 
and lysis of ME-180 cervical epithelial cells.  Equal numbers of each bacterial species 
were added to a confluent monolayer of ME-180 cervical epithelial cells.  Cytotoxicity 
scores (Table 4) and microscopic images (Figure 8) of the monolayer were recorded after 
4 hours.  As shown in Figure 8, only the G. vaginalis strains induced rounding and cell 
death of the ME-180 cells.  All of the G. vaginalis strains were given a score of 5 on the 
cytotoxicity scale, indicating complete lysis of the monolayer within 4 hours.  All other 
anaerobes tested lacked detectable cytotoxic activity and remained a zero on the 
cytotoxicity scale.  Each experiment was repeated three times with similar results. 
 
Biofilm formation by BV-associated anaerobes 
 Biofilm assays were performed to analyze the biofilm-forming potential of G. 
vaginalis and other BV-associated anaerobes.  When cultured overnight on tissue-culture-
treated polystyrene, G. vaginalis stains 5-1, 465 and 101-1 produced a thick, tenacious 
biofilm (Figure 9A).  F. nucleatum was able to produce a moderate, fluffy biofilm that 
was partially dislodged by washing.  The ease with which F. nucleatum biofilms were 
dislodged by washing is reflected by the large standard deviation in Figure 9B.  The other 
anaerobes tested:  A. vaginae, M. mulieris, P. bivia, Veillonella, Peptostreptococcus, and  
Figure 7.  Cytotoxicity caused by G. vaginalis strains is contact-dependent.  
Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours.  Equal numbers 
of bacteria were loaded into trans-well filters containing either 0.45 !m or 8 !m 
pores.  The cells were monitored microscopically every hour for a 4 hour incubation 
and light microscopy images were taken after the 4 hour incubation. (magnification 
100x) 
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Figure 8.  Cytotoxic changes of cervical epithelial cell monolayers challenged 
with various BV-associated anaerobes.  Bacteria were grown in sBHIG 
anaerobically at 37ºC for 24 hours, standardized to ensure equal numbers, added 
cervical epithelial cells and incubated for 4 hours.  Light microscopy images were 
taken after the 4 hour incubation.  P. bivia strain BVD is not shown but was similar 
to P. bivia strain 29303, which did not exhibit cytotoxicity. (magnification 1000x) 
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Figure 9.  Biofilm formation of G. vaginalis strains and various BV-associated 
anaerobes.  (A)  Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours.  
Nonadherent cells were removed from the wells and the adherent bacteria were 
stained with safranin.  OD595 readings were determined to ensure similar growth of 
each species.  Experiments were repeated 3 times with similar results and a 
representative image is shown.  (B)  Quantitiative assessment of the biofilm-
forming capacities were made by dissolving the safranin stain in 33% acetic acid 
and measuring OD562.  8 technical replicates and 3 biologic replicates (N=24) were 
performed on each stain and the absorbance readings were averaged.  Error bars 
represent standard deviations.  P. bivia strain BVD is not shown but was similar to 
P. bivia strain 29303, which did not exhibit biofilm formation. 
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Peptoniphilus, demonstrated significantly lower biofilm formation relative to G. vaginalis 
(student’s t-test, p<0.0001). 
 
Discussion 
 Despite the fact that G. vaginalis can be isolated in greater than 95% of BV cases, a 
study with healthy human volunteers indicating that pure cultures of the bacteria did not 
always cause BV, cast perpetual doubt on its pathogenic potential (Gardner and Dukes 
1955; Criswell, Ladwig et al. 1969).  However, the link between vaginolysin and BV along 
with studies showing G. vaginalis as the predominant species in the biofilm that forms on 
the vaginal epithelium during BV suggests that the role of this species as a pathogen 
should be readdressed. 
 As animal models for BV are lacking, we designed a series of in vitro experiments 
to compare the relative virulence capacities of G. vaginalis and other BV-associated 
anaerobes.  Adherence is a key first step in pathogenesis, as a potential pathogen must first  
adhere to host tissues in order to avoid clearance by host defense mechanisms such as the 
mucociliary escalator, urine flow, and the flow of vaginal secretions.  Furthermore, 
adherence is the first step in the formation of a biofilm and the capacity to form a biofilm 
on polystyrene is irrelevant to pathogenesis unless the bacteria can first adhere to the 
vaginal epithelium.  We therefore analyzed the ability of BV-associated anaerobes to 
adhere to cervical epithelial cells in tissue culture.  Only, G. vaginalis and Peptoniphilus 
adhered avidly to ME-180 cervical epithelial cells.  G. vaginalis tended to form clumps of 
bacteria that adhered to epithelial cells, while Peptoniphilus was more evenly distributed 
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around the borders of the epithelial cells.  Our data confirms previous studies showing that 
G. vaginalis adheres to McCoy cells and human red blood cells (Scott, Curran et al. 1989).  
Peptoniphilus has been only recently named and is associated with persistent cases of BV, 
with 36% of persistent cases of BV having the organism (Marrazzo, Thomas et al. 2008).  
This is the first study demonstrating its robust adherence to cervical epithelial cells, which 
is an interesting and potentially important observation.  Perhaps Peptoniphilus associates 
with G. vaginalis during cases of BV and leads to the pathogenesis seen with the disorder; 
this hypothesis warrants more research into the role Peptoniphilus plays in the 
pathogenesis of BV.  A. vaginae and F. nucleatum exhibited only moderate adherence, and 
adherent M. mulieris, P. bivia and Peptostreptococcus were not detected.  The process of 
dental biofilm formation is initiated by bacterial species with affinity for the tooth pellicle 
such as the streptococci and actinomycetes.  These species are referred to as initial 
colonizers.  Other bacterial species adhere to the initial colonizers and this leads to the 
development of a complex biofilm community composed of a large variety of species, 
many of which are unable to adhere to teeth on their own.  Specifically, F. nucleatum 
expresses receptors that adhere to a large variety of other bacterial species and acts as a 
bridge between early and late colonizers (Kolenbrander, Andersen et al. 2002; Periasamy 
and Kolenbrander 2009).  Because G. vaginalis is able to adhere to and form a biofilm on 
cervical epithelia, it is plausible that it is an initial colonizer that paves the way for 
additional species with low innate pathogenic potential to become established in the 
vagina.   
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 The production of a cytolysin by G. vaginalis was first reported in 1990, but has 
only recently been named vaginolysin and characterized as a pore-forming cytotoxin which 
utilizes the complement regulatory molecule CD59 to activate the epithelial p38 mitagen 
activated protein kinase pathway in human epithelial cells, leading to cell death (Rottini, 
Dobrina et al. 1990; Gelber, Aguilar et al. 2008).  IgA antibodies against vaginolysin have 
been linked to the mucosal immune response during BV, further supporting the role of 
vaginolysin in BV pathogenesis (Cauci, Driussi et al. 2002).  We analyzed the relative 
cytotoxic activity levels of the BV-associated anaerobes and found that only G. vaginalis 
was able to induce rounding and lysis of ME180 cervical epithelial cells.  The other BV-
associated species did not elicit detectable cytopathologic changes, even when the bacteria 
were incubated with the ME180 cells overnight (data not shown).  It is important to note 
that the cytotoxic effect of G. vaginalis was contact dependent; this phenotype has been 
described in Streptococcus pyogenes which utilizes an injection pathway for streptolysin O 
called cytolysin-mediated translocation (Madden, Ruiz et al. 2001).  The streptolysin O 
forms a pore in the eukaryotic cell through which an effector is translocated and the 
cytolysin and effector act synergistically to trigger cytoxicity (Madden, Ruiz et al. 2001).  
Future studies should analyze whether vaginolysin is transported by cytolysin-mediated 
translocation and if it helps move effector molecules into cervical epithelial cells. 
Next, we analyzed biofilm formation.  Biofilm formation is an important virulence 
factor because it confers heightened antibiotic tolerance and resistance to host immune 
defenses.  Due to the fact that biofilm bacteria are not effectively cleared by the immune 
system or completely killed by antibiotics, biofilm-related infections tend to be chronic 
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and/or relapsing.  BV tends to be a smoldering infection with a high rate of relapse or 
recurrence.  Indeed, direct evidence from the microscopic analysis of vaginal biopsies of 
women with BV revealed the presence of a bacterial biofilm on the vaginal epithelium 
(Swidsinski, Mendling et al. 2005).  A follow-up study revealed that metronidazole therapy 
failed to clear the biofilm and suggested that this was related to relapse (Swidsinski, 
Mendling et al. 2008).  These studies revealed biofilm formation as an important virulence 
determinant in BV.  In our in vitro assay, G. vaginalis formed a moderate or strong 
biofilm, depending on the strain and F. nucleatum formed a moderate biofilm that was 
easily dislodged.  None of the other BV-associated anaerobes were able to from a 
significant biofilm. 
 Our study did not include all of the bacterial species found to be associated with 
cases of BV.  BV is a polymicrobial disorder and the diversity of species associated with 
the disorder continues to increase as detection methods such as 16S rRNA gene 
pyrosequencing improve.  Because of the large number of candidates and because many 
bacteria found to be associated with BV are unculturable, we focused instead on a 
relatively small number of commonly isolated species.  The in vitro model of adherence 
used in this study is limited by the fact that cell monolayers of ME180s are not polarized as 
are cervical epithelial cells in vivo.  The assay for biofilm formation is limited by the fact 
that the growth medium does not contain the same factors found in vivo and some in vivo 
cues may turn on expression of biofilm-related genes.  These limitations aside however, in 
vitro models can be very informative and are key to furthering our understanding of BV as 
the lack of a tractable animal model for BV has thwarted efforts to understand the etiology 
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of this common and important women’s health concern.  While it is plausible that our in 
vitro study did not test for virulence properties that play an important role in BV 
pathogenesis or that the conditions used did not allow for full expression of virulence 
factors, our results are suggestive of a higher innate virulence potential of G. vaginalis 
relative to other BV-associated species.  While a number of the BV-associated anaerobes 
had one of the three virulence properties tested, only G. vaginalis displayed robust 
cytotoxicity, strong adherence to vaginal epithelial cells and a propensity to form a dense 
biofilm, suggesting a key role for G. vaginalis in BV pathogenesis.  Additional virulence 
factors produced by G. vaginalis include sialidase and prolidase, two hydrolytic enzymes 
that may have a role in degrading several key mucosal protective factors, such as mucins, 
as well as contributing to exfoliation and detachment of vaginal epithelial cells (Cauci, 
Culhane et al. 2008).  In sum, there is strong evidence that G. vaginalis does possess innate 
pathogenic potential.  Other BV-associated anaerobes may also have as yet un-described 
virulence factors, or may be more pathogenic in the presence of other species.  It is also 
likely that the primary etiologic agent of BV, if there is one, varies on a case-by-case basis.  
However, this study suggests that due to its collection of virulence factors, it is likely that 
G. vaginalis has a pathogenic capacity and could be the key agent in certain cases of BV. 
 Although we have shown that G. vaginalis is able to form a thick, tenacious 
biofilm, not much is known about how G. vaginalis actually forms this biofilm.  Many 
bacteria are able to produce biofilms and this biofilm mode of growth imparts tolerance to 
many negative environmental stimuli; therefore, in order to produce therapies that have 
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higher efficacy and lower rates of relapse, it is imperative to characterize the biofilm 
produced by G. vaginalis. 
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CHAPTER 4 
 
Characterization of the Gardnerella vaginalis biofilm matrix 
 
 
 
Introduction 
 Recent evidence suggests that, in many infections, bacteria assume a biofilm rather 
than a planktonic mode of growth.  Biofilms are adherent communities of microorganisms 
that are held together by a polymeric matrix that is composed of polysaccharides, proteins, 
and/or nucleic acids.  The distinct gene expression pattern and the physical structure of 
biofilms increase bacterial resistance to many negative stimuli.  Bacterial biofilm 
infections are particularly problematic because the biofilm phenotype allows for increased 
tolerance to antibiotics, inhibition of normal immune responses, and an increase in 
difficulty of eradicating the infection.  Biofilm cells are capable of persisting in the 
presence of antimicrobials at concentrations that are 1,000-fold higher than those necessary 
to eradicate planktonic bacteria (Hamilton 2002; Cerca, Martins et al. 2005).  Biofilm 
infections can become chronic and recalcitrant; treatment often results in long periods of 
hospitalization, morbidity, severe functional impairment and increased mortality 
(Chaignon, Sadovskaya et al. 2007).  Because of this, biofilm research has focused on 
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analyzing the architecture, antibiotic resistance profile and gene expression in biofilms in 
order to improve current antibiotic therapy and discovery of novel targets for therapy. 
 Although BV does not have a high rate of morbidity and mortality, it is associated 
with a high rate of relapse or recurrence.  This is due to the fact that in most cases of BV, a 
thick, adherent biofilm, with G. vaginalis being the predominant species, forms on the 
vaginal epithelium (Swidsinski, Mendling et al. 2005).  In addition, previous studies show 
that G. vaginalis biofilms can tolerate higher concentrations of certain antibiotics (Muli 
and Struthers 1998; Swidsinski, Mendling et al. 2008).   We hypothesize that the biofilm 
phenotype confers a survival advantage on BV-associated anaerobes within the vagina and 
is an important component of the pathogenesis of BV.   
 In order to combat the high rate of recurrence seen with BV, new therapeutic 
modalities need to be developed.  Some researchers speculate that introduction of probiotic 
strains of lactobacilli, or ones in which copious amounts of lactic acid and hydrogen 
peroxide are produced, could kill the biofilm bacteria and repopulate the vagina.  We 
hypothesize that elaboration of a biofilm could enable G. vaginalis to survive, even in the 
presence of lactobacilli-derived H2O2 and lactic acid, and therefore probiotic therapy will 
prove ineffective.  To test this we compared sensitivities of biofilm vs. planktonic cultures 
to H2O2 and lactic acid.   
The most promising new therapies for BV are ones in which the biofilm matrix is 
targeted, leaving more susceptible planktonic bacteria in the place of biofim.  It has been 
shown that some bacteria, like Actinobacillus actinomycetemcomitans, produce a biofilm 
dispersing enzyme that allows bacteria to be released from the biofilm matrix to populate 
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other locations (Kaplan, Ragunath et al. 2003).  The enzyme is called Dispersin B (DspB) 
and it has been shown to disperse biofilms composed of # (1,6)-linked N-
acetylglucosamine.  Other enzymes with biofilm dispersing potential are 
deoxyribonucelase 1 (DNase1) which has been shown to degrade P. aeruginosa biofilms 
(Barken, Pamp et al. 2008), streptokinase (Varidase) which has been shown to degrade S. 
aureus biofilms (Nemoto, Hirota et al. 2000) and proteases from the Antarctic krill shrimp 
referred to as Krillase which have been shown to degrade oral biofilms (Berg, Kalfas et al. 
2001).   
Other agents that are not designed to specifically target biofilms also have biofilm-
dispersing properties. For examples, sodium metaperiodate hydrolyzes carbon:carbon 
bonds and degrades certain polysaccharides, and can therefore disperse biofilms with 
susceptible polysaccharide matrices. Proteases like trypsin and proteinase K can degrade 
bacterial biofilms that require a proteinaceous component for intercellular adhesion 
(Chaignon, Sadovskaya et al. 2007; Badel, Laroche et al. 2008; Fredheim, Klingenberg et 
al. 2009).  
The plant cysteine-proteinases bromelain, papain and ficin offer a wide spectrum of 
therapeutic efficacies; they demonstrate in vitro and in vivo, antiedemateous, anti-
inflammatory, antithrombotic and fibrinolytic activities and may prove more specific and 
less harmful to human tissue (Maurer 2001; Tysnes, Maurer et al. 2001).  Bromelain is a 
crude extract from the stems and immature fruits of pineapples, constituting an unusually 
complex mixture of different thiol-endopeptidases, phosphatases, glucosidases, 
peroxidases, cellulases, and glycoproteins (Taussig and Batkin 1988; Maurer 2001).  
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Papain is found in the latex of the papaya fruit and along with bromelain, has been used 
therapeutically in wound debridement (Kravitz, McGuire et al. 2008; Ramundo and Gray 
2008).  Ficin is derived from fig latex and has been shown to have a negative effect on the 
cuticle of nematodes and therefore has antihelmintic activity (de Amorin, Borba et al. 
1999; Stepek, Buttle et al. 2005).  Finally, Pepsin is an enzyme whose precursor is released 
by the chief cells in the stomach and upon contact with the hydrochloric acid is 
autocatalytically cleaved to activate itself.  Pepsin degrades food proteins into peptides and 
functions best in acidic environments (Fruton 2002). 
The architecture and matrix material of G. vaginalis biofilms has not yet been 
characterized. Therefore, in this study, we employed biochemical assays to determine the 
amounts of protein, carbohydrate and nucleic acid found in the biofilm matrix.  We 
employed lectin blots to identify any polysaccharide component and used confocal 
microscopy to characterize the biofilm architecture.  Finally, we treated the biofilms with a 
variety of compounds to determine which class of compounds was able to disperse the 
bacteria. 
 
Results 
Biofilm formation by G. vaginalis in vitro   
To determine optimal conditions for in vitro biofilm formation, G. vaginalis was 
cultured anaerobically in 96-well plates in Luria Bertani broth (LB), Tryptic Soy broth 
(TSB), Brain Heart Infusion broth (BHI), Mueller Hinton broth (MH), Man, Rogosa and 
Sharpe broth (MRS), or a chemically defined medium resembling vaginal secretions 
  90 
(CDM) (Geshnizgani and Onderdonk 1992).  Because glucose increases biofilm formation 
in other bacterial species (Hall-Stoodley and Stoodley 2002), G. vaginalis was also 
cultured in the presence of 1% glucose (LBG, TSBG, BHIG, MHG, MRSG and CDMG).  
Biofilms were stained with safranin, which binds to DNA, polysaccharides and other 
biologic materials and imparts a red color to biofilms.  As shown in Figure 10, biofilm 
formation was poor in LB, TSB, TSBG, MRS and MRSG.  Optimal biofilm formation was 
observed in BHI with1% glucose. 
 
Biochemical characterization of G. vaginalis biofilms   
The crude biochemical composition of the extracellular matrix of G. vaginalis 
biofilms was characterized by extracting loosely-associated material from biofilm and 
planktonic bacteria.  Protein concentrations in the extracts were determined with the use of 
Coomassie Protein Assay Reagent and the Bradford assay, nucleic acid content was 
estimated by measuring the optical density at 260 nm, and carbohydrate content was 
estimated by the standard phenol-sulfuric acid assay with the use of glucose dilutions as 
standards.   Biofilm extracts contained more than 4 times as much total carbohydrate per 
10
6
 bacterial cells compared to planktonic bacteria (Table 5) but protein and nucleic acid 
concentrations were not significantly different (p>0.05 and p>0.5, respectively) suggesting 
that neither proteins nor nucleic acids are a major component of the extracellular biofilm 
matrix. 
 To further characterize the carbohydrate component of the biofilm matrix, matrix 
extracts were blotted onto nitrocellulose membranes and probed with various lectins,  
 Figure 10.  Biofilm formation by G. vaginalis in vitro in different media.  G. 
vaginalis strain ATCC 49145 was grown in various media with or without added 
glucose anaerobically at 37ºC for 24 hours.  Non-adherent cells were removed from 
the wells and the adherent bacteria were stained with safranin.  Strains 465 and 5-1 
produced similar results.   
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mg protein# mg nucleic acid*# mg carbohydrate# 
Planktonic 0.44 ± 0.06 0.13 ± 0.01 0.28 ±0.09 
Biofilm 0.21 ± 0.14 0.14 ± 0.02 1.23 ± 0.5! 
# mg of protein, nucleic acid and carbohydrate are all per 109 CFU of 
bacteria 
* Nucleic acid concentration in mg nucleic acid/109 CFU were calculated 
using the equation OD260Xdilution factorX0.05 
! p<0.05 by Student’s t-test 
Table 5.  Biochemical analysis of extracts from planktonic and biofilm 
bacteria. 
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which are sugar-binding proteins that are highly specific for their sugar moieties, which 
were conjugated to horseradish peroxidase (HRP).  Glycine Max, which binds to N-
acetylgalactosamine bound weakly to extracts from biofilms grown in CDM but not to 
planktonic extracts or extracts from biofilms grown in BHI (Figure 11B).  Concanavalin 
A, which binds to "-mannose and "-glucose, did not bind to extracts from biofilms or 
planktonic bacteria (Figure 11C).  Wheat germ agglutinin, which binds to N-
acetylglucosamine, reacted with all extracts, but biofilm bacteria grown in BHI contained 
approximately 25-fold more of the material that reacted with the lectin in comparison to 
planktonic bacteria grown in BHI (Figure 11A) suggesting that N-acetlyglucosamine is a 
major component of the biofilm matrix. 
 
Structural analysis of G. vaginalis biofilms   
Confocal microscopy was used to further analyze the N-acetylglucosamine-
containing polysaccharide component of G. vaginalis biofilms cultured in BHIG.  Biofilm 
bacteria were stained with the green nucleic acid stain SYTO® 9 and Alexa Fluor® 633-
conjugate of Wheat germ agglutinin, which binds to polysaccharides within the biofilm 
matrix.  Figure 12 shows that the biofilm was ~44 !m thick and exhibited a characteristic 
heterogeneous biofilm structure with peaks and “valleys” and microcolonies separated by 
channels.  WGA adhered to material around the bacteria (red), but did not co-localize with 
the nucleic acid stain (green) suggesting that, as expected, the carbohydrate was 
extracellular and possibly only loosely associated with the cell surface. 
 
Figure 11.  Lectin blots of biofilm extracts react with Wheat germ agglutinin 
(WGA) but not with Concanavalin A (ConA) or Glycine max (Gly).   Serial 5-
fold dilutions of extracts from biofilms grown in BHI, BHIG, or CDM and 
planktonic cultures grown in BHI or CDM were blotted onto nitrocellulose and 
probed with peroxidase-conjugated lectins.  Panel A was probed with WGA-HRP, 
panel B was probed with Gly-HRP and panel C was probed with ConA-HRP. 
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Figure 12.  Confocal microscopy of G. vaginalis biofilm structure.  Biofilms 
were stained with SYTO® 9 and a fluorescent Alexa Fluor® 633-conjugate of 
WGA and analyzed by confocal scanning laser microscopy.  The large panel is a 
“bird’s-eye view of the biofilm.  The right panel is a side view of an x-axis section 
and the lower panel is a side-view of the y-axis section.  Green color indicates 
nucleic acid while red staining indicates presence of polysaccharide.  The biofilm 
shown was formed by strain 465; biofilms formed by other strains yielded similar 
results. 
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Sensitivity of G. vaginalis biofilms versus planktonic cultures  
To determine if biofilm bacteria were more resistant than planktonic bacteria to 
H2O2 and lactic acid, we exposed biofilm and planktonic cultures to these agents and 
determined their viability by luciferase assay.  The luciferase reagent is added directly to 
the bacterial cells; it supports bacterial cell lysis and generation of a luminescent signal.  
The luminescent signal is proportional to the amount of ATP present, which is directly 
proportional to the number of viable cells in culture.  When reproducing these results with 
G. vaginalis, Figure 13A demonstrates that the relative light units (RLU) emitted from the 
luciferase assay directly related to the number of colony forming units of G. vaginalis 
present.  Figure 13B and 13C show the MBC90’s (minimum concentration required to 
reduce viability by at least 90%) for H2O2 and lactic acid.  Biofilms were more resistant 
and tolerated 4-fold higher concentrations of H2O2 and 8-fold higher concentrations of 
lactic acid than planktonic cultures.   
 To better replicate the conditions that G. vaginalis would encounter in the vagina, 
we grew biofilms and planktonic cultures in CDM and tested the sensitivity of the cultures 
to H2O2 and lactic acid.  As shown in Figure 13, biofilms grown in CDM were resistant to 
4-fold higher concentrations of H2O2 and 4-fold higher concentrations of lactic acid. 
 
Dissolution of G. vaginalis biofilms   
We hypothesized that degradation of the exopolysaccharide component within the 
biofilm matrix would lead to dissolution of the biofilms and would restore sensitivity to 
different agents.  To test this, biofilms were treated with sodium metaperiodate, which  
Figure 13.  Sensitivity assays demonstrate that biofilms exhibit increased 
tolerance to H2O2 and lactic acid.  (A) Illustrates the direct correlation between 
the number of colony forming units (x-axis) and relative light units (y-axis) 
measured in the viability assay.  (B) Shows the MBC90 of H2O2, or the 
concentration required to decrease viability of biofilms and planktonic cultures 
grown in BHI or CDM by at least 90% is shown.  (C) Shows the concentration of 
lactic acid required to decrease viability of biofilm and planktonic cultures grown in 
BHI or CDM by at least 90% is shown.  Bars in Panels B and C represent the 
averages of three separate experiments and error bars represent the standard 
deviations. 
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hydrolyzes polysaccharide, and chitinase, which degrades beta-1,4-linked polymers of N-
acetylglucosamine.  As shown in Figure 14, chitinase reduced the biofilm thickness only 
very slightly, even at the highest concentration tested and sodium metaperidoate had no 
effect.  
 We then tested other catabolic enzymes and compounds on mature biofilms to 
determine their biofilm-dispersing activities (Figure 15).  Concentrations of proteinase K  
and trypsin as low as 32 !g/ml and 6.4 !g/ml (respectively) effectively disrupted the 
biofilms produced by all three strains.  H2O2, lactic acid, SDS, and DNaseI, which have 
been shown to disrupt some Pseudomonas aeruginosa biofilms, did not have an effect 
(Whitchurch, Tolker-Nielsen et al. 2002). 
 
Effect of Proteinase K on biofilm structure   
Confocal microscopy was used to further analyze the structural changes associated 
with proteinase K treatment of G. vaginalis biofilms.   For the proteinase K time course, 
stained biofilms were treated with 100 !g proteinase K/mL and confocal images of the 
same field of view were collected every 20 minutes for 280 minutes.  Figure 16 shows the 
proteinase K time course; at time zero microscopy revealed a thick, characteristically 
heterogeneous G. vaginalis biofilm with peaks and “valleys” and microcolonies separated 
by channels.  By 40 minutes, the structure of the G. vaginalis biofilm was lost, with no 
microcolonies or channels remaining.  By the end of the time course, no distinguishable 
biofilm remained.  This shows that proteinase K is effectively cleaving a component of the 
biofilm that is very important in structure and architecture.  Because proteinase K cleaves  
Figure 14.  Treatment of G. vaginalis biofilms with chitinase and sodium 
metaperiodate.  G. vaginalis strain 465 was grown as a biofilm and treated for 20 
hours at 37ºC with chitinase and sodium metaperiodate.  The reagents were serially 
diluted 5-fold horizontally across the plate.  The biofilm wells were washed and 
stained with safranin to shown biofilm dissolution as a decrease in red color.  
Biofilms formed by strains 5-1 and ATCC 49145 yielded similar results. 
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Figure 15.  Treatment of G. vaginalis biofilms with proteases.  G. vaginalis 
strain 465 was grown as a biofilm and treated for 20 hours at 37ºC with proteinase 
K, trypsin, H2O2, lactic acid, SDS or DNaseI.  The reagents were serially diluted 5-
fold horizontally across the plate.  The biofilm wells were washed and stained with 
safranin to shown biofilm dissolution as a decrease in red color.  Biofilms formed 
by strains 5-1 and ATCC 49145 yielded similar results. 
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Figure 16.  Effect of proteinase K treatment on biofilm structure over time.  
Biofilms were stained with Live/Dead BacLight staining and analyzed by confocal 
scanning laser microscopy.  The large panels are a “bird’s-eye view of the biofilm.  
The right panels are a side view of an x-axis section and the lower panels are a side-
view of the y-axis section.  Images were taken every 20 minutes for a total of 280 
minutes. Red color indicates viable bacteria while green color indicates dead 
bacteria.  The biofilm shown was formed by strain 465; biofilms formed by other 
strains yielded similar results. 
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proteins, this points to a proteinaceous adhesin playing an important role in G. vaginalis 
biofilm structure and architecture. 
 
Effect of biofilm dissolution on sensitivity  
To determine whether proteolytic dissolution of biofilms would restore the MBC90 
to levels associated with planktonic bacteria, we pre-treated biofilms with proteinase K to 
degrade the biofilm structure before adding H2O2 and lactic acid.  Proteinse K alone did 
not affect bacterial viability (data not shown); however, treatment of biofilms with the 
protease significantly increased the sensitivities to H2O2 and lactic acid back to planktonic 
levels (Figure 17). 
 
Effect of natural proteases on G. vaginalis biofilm 
 To determine the ability of natural proteases to degrade the G. vaginalis biofilm, 24 
hour biofilms were grown anaerobically, then subjected to 5-fold dilutions of ficin, 
bromelain, papain and pepsin in either PBS pH 7.4, which would represent how the 
enzyme could be potentially stored, and PBS pH 4.5, which would represent the average 
pH of the vagina during BV.  Stock concentrations used were 10 U of bromelain and 
papain, 5.78 U of ficin and 345 U of pepsin.  Figure 18A shows representative images of 
the degradation seen with each protease; both pH conditions gave similar results.  The best 
degradation was seen with the enzyme ficin.  Ficin was highly effective at degrading G. 
vaginalis biofilms at both pH 7.4 and pH 4.5.  At the highest concentration of enzyme 
tested, 5.78 Units, ficin exhibited 93 and 92% biofilm reduction at pH 7.4 and 4.5,  
Figure 17.  Sensitivity of proteinase-K-treated biofilms to H2O2 and lactic acid.  
The concentrations of H2O2 (A) and lactic acid (B) required to decrease viability of 
planktonic cultures, biofilms and proteinase-K-treated biofilms by at least 90% are 
shown.  Proteinase-K treated biofilm cultures exhibited sensitivities similar to that 
of planktonic cultures.  Bars represent the averages of three separate experiments 
and error bars represent the standard deviations. 
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respectively (Figure 18B).  Bromelain was also an effective biofilm degrading agent 
regardless of pH, it was able to cause a 76% reduction in biofilm mass (Figure 18B). 
Similar efficient degradation was seen with papain; at the highest concentration of enzyme 
tested, papain exhibited 89 and 85% biofilm reduction at pH 7.4 and 4.5, respectively 
(Figure 18B).  The enzyme pepsin was not effective at degrading G. vaginalis biofilms 
(Figure 18A and 18B).  Table 6 shows the amount of enzyme required to reduce G. 
vaginalis biofilm density by at least 75% at pH 7.4 and 4.5; this enzyme concentration 
could have therapeutic potential when used in conjunction with antibiotics.  The percent 
biofilm reduction for each enzyme concentration tested is seen in Appendix A. 
  
Effect of natural protease papain on antibiotic sensitivity of G. vaginalis 
To determine the ability of the enzyme papain to increase the sensitivity of G. 
vaginalis to the antibiotic clindamycin, 24 hour biofilm and planktonic cultures were 
grown anaerobically at 37°C.  Biofilms were either treated with BHIG as a control, with 10 
U of papain as a control, or with 3 times the MIC of clindamycin (1.84 !g/ml) in BHIG, 
then incubated for 16 hours before bacteria were harvested, diluted and plated for CFU.  
Biofilms were either dispersed with 10 U of papain for 2 hours prior to treatment with 
clindamycin and nonadherent bacteria were removed by washing, or clindmycin was added 
directly to papain and allowed to incubate for 16 hours before bacteria were harvested, 
diluted and plated for CFU.  Planktonic cultures were either treated with BHIG or 
clindamycin as a control for 16 hours before bacteria were harvested, diluted and plated for  
Figure 18.  Treatment of G. vaginalis biofilms with natural proteases.  G. 
vaginalis strain 5-1 was grown as a biofilm and treated for 20 hours at 37ºC with 
ficin, bromelain, papain and pepsin.  The reagents were serially diluted 5-fold 
horizontally across the plate.  The biofilm wells were washed and stained with 
safranin to shown biofilm dissolution as a decrease in red color.  (A) Images of 
stained biofilms.  (B) Quantitative measures of biofilm degradation.  Stained G. 
vaginalis biofilms were resolublized in 33% acetic acid and optical density of the 
solution was measured at 562 nm.  The percentage of biofilm reduction was 
calculated using the equation described in the text.  Biofilms fomed by strains 5-1 
and ATCC 49145 yielded similar results. 
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345 U Control 
5-fold dilutions 
A. 
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Table 6.  Amount of enzyme required to reduce biofilm density by at least 
75% at pH 4.5 and pH 7.4.  (N/A indicates that pepsin was unable to 
reduce biofilm density by at least 75%, even at the highest enzyme 
concentration tested, 345U) 
Proteases pH 4.5 pH 7.4 
Bromelain 10 U 0.4 U 
Papain 0.4 U 0.4 U 
Ficin 0.2312 U 1.156 U 
Pepsin N/A N/A 
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CFU.  Figure 19 shows the CFU counts of bacteria treated under various conditions.  
Clindamycin was able to reduce the CFU count of biofilm bacteria by approximately 70%; 
however, no recoverable bacteria were seen when planktonic bacteria were treated with the 
same amount of antibiotic.  This showcases the need to find a compound that can help 
reduce the resistance of biofilm bacteria to antibiotics.  When the biofilm was first 
dispersed by papin and nonadherent cells removed by washing, this was able to reduce the 
CFU count of biofilm bacteria by approximately 98%.  When clindamycin was added 
directly to papain and allowed to interact with the biofilm, it reduced the CFU count of 
biofilm bacteria by approximately 95%.  Papain itself was able to reduce the CFU count of 
biofilm bacteria; therefore, more research is needed into whether papain acts in 
conjunction with the antibiotic, or if the enzyme is all that is needed to reduce the 
recoverable CFUs.  This data suggests that papain treatment in combination with an 
antibiotic could be an effective new therapy for BV. 
 
Discussion 
 The etiology and pathogenesis of BV have remained enigmatic ever since initial 
reports of the condition in 1954 (Gardner and Dukes 1954).  Confounding issues include 
the polymicrobial nature of BV and the role of host factors, both genetic and behavioral.  
The recent demonstration that BV is associated with the formation of a biofilm in which 
the predominant species is G. vaginalis (Swidsinski, Mendling et al. 2005) is an important 
advance towards understanding its pathogenesis.  We therefore sought to develop a simple  
Figure 19.  Treatment of G. vaginalis biofilm with papain increased the 
sensitivity to antibiotic challenge.  24 hour biofilm and planktonic cultures were 
grown anaerobically in BHIG at 37°C.  Biofilms were treated with either BHIG as a 
control (Control), 10 U of papain in BHIG as a control, 1.8375 !g/ml of 
clindamycin in BHIG (Clindamycin),  papain and clindamycin in BHIG (Prot + 
Clinda), or biofilms were dispersed with 10 U of papain for 2 hours prior to 
treatment with clindamycin (Wash, Clinda).  Planktonic cultures were treated with 
BHIG as a control or clindamycin (Planktonic Clinda).  The cultures were 
incubated for 16 hours anaerobically at 37°C and bacteria were harvested, 10-fold 
diluted and plated for CFU. 
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model for studying G. vaginalis biofilms in vitro.  We found that when cultured 
anaerobically in BHI + 1% glucose, the bacteria formed a thick, tenacious biofilm on 
polystyrene.  
 Growth of G. vaginalis is normally suppressed by healthy lactobacilli.  This 
inhibition is attributed to the production of lactic acid and H2O2.  We hypothesized that the 
formation of a biofilm would increase the resistance of the bacteria to H2O2 and lactic acid 
leading to colonization even in the presence of lactobacilli.  Bacterial sensitivity is 
normally assessed by analyzing the minimum inhibitory concentration (MIC) required to 
inhibit the growth of suspension of bacteria at low cell density.  This type of assay cannot 
be used to measure biofilm sensitivities because the bacteria within biofilms are at a high 
cell density.  We therefore measured bacterial viability of biofilms and high cell density 
planktonic cultures using a luciferase reagent that quantitatively measures ATP.  Using this 
method, MBC90’s, or the concentrations required to reduce viability by at least 90%, for 
planktonic bacteria were ~0.2 mM H2O2 and ' 125-250 mM lactic acid.  The 
concentrations of lactic acid required to kill G. vaginalis were considerably higher than the 
amounts reported to be secreted by lactobacilli (~30-60 mM) (McLean and McGroarty 
1996), but since our assay measured bactericidal rather than bacteriostatic activity, it is 
possible that the concentration of lactic acid required to suppress growth is lower.  Biofilm 
cultures were more resistant and tolerated 4-5 fold higher concentrations of H2O2 and 4-6 
fold higher concentrations of lactic acid than planktonic cells.  The finding that 
concentrations of H2O2 (0.8-1.3 mM) and lactic acid (1,000 mM) required to produce a 
90% decrease in viability in biofilm bacteria were substantially greater than the MBC90’s 
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for planktonic bacteria, could imply that G. vaginalis forms a biofilm in the vaginal 
environment in order to resist the detrimental effects of lactic acid- and H2O2-producing 
lactobacilli. 
 We hypothesized that enzymatic dissolution of biofilms would restore the 
sensitivity to H2O2 and lactic acid to planktonic-like levels.  In order to find a compound to 
dissolve the biofilms, we preliminarily characterized the composition of the biofilm matrix.  
Biochemical analysis suggested that the extracellular matrix of the biofilms was 
predominantly composed of carbohydrate rather than protein and/or nucleic acid.  Most 
previously characterized biofilms contain an exopolysaccharide intercellular adhesion so it 
is likely that the carbohydrate component we detected is a polysaccharide (Heilmann, 
Schweitzer et al. 1996; Kaplan, Ragunath et al. 2004; Wang, Preston et al. 2004; 
Overhage, Schemionek et al. 2005).  Wheat germ agglutinin, a lectin from Triticum 
vulgaris bound to the matrix material, suggesting that the matrix contains N-
acetylglucosamine.  We therefore tested chitinase, an enzyme that cleaves the #-1-4 
linkage between N-acetylglucosamine residues in chitin, for the ability to dissolve G. 
vaginalis biofilms.  At the highest concentration tested, chitinase reduced the biofilm 
thickness only slightly.  The extracellular polysaccharide adhesion involved in biofilm 
formation by a variety of unrelated bacterial species including Staphylococcus aureus and 
S. epidermidis, E. coli and Actinobacillus actinomycetemcomitans is a #-1-6-linked 
polymer of N-acetylglucosamine referred to as PGA or PNAG (McKenney, Hubner et al. 
1998; Kaplan, Velliyagounder et al. 2004; Wang, Preston et al. 2004).  The #-1-6-linkage 
of PNAG is resistant to chitinase and it is possible that the polysaccharide matrix of G. 
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vaginalis biofilms has a similar structure and is therefore not degraded by chitinase.  We 
also tested sodium metaperiodate, which cleaves polysaccharides by oxidation and 
chemical cleavage of carbon-carbon bonds for biofilm dissolving activity.  Surprisingly, 
sodium metaperiodate did not affect the G. vaginalis biofilms.  It is possible that a 
component of the biofilms affected sodium metaperiodate activity or that other non-
polysaccharide based adhesions are involved.  Even though our biochemical analyses did 
not suggest a significant nucleic acid component to the biofilms, we tested DNaseI against 
G. vaginalis biofilms. It is known that P. aeruginosa biofilm matrix contains a significant 
amount of nucleic acid and that these biofilms are dispersed by DNaseI treatment 
(Whitchurch, Tolker-Nielsen et al. 2002).  However, no degradation of G. vaginalis 
biofilms by DNaseI was observed.  Treatment of the biofilms with the proteases proteinase 
K and trypsin did, however, effectively remove the biofilm from the polystyrene wells.  
Biofilm extracts did not contain significantly more protein than planktonic bacteria 
suggesting that the extracellular matrix is not largely proteinaceous.  It is possible 
however, that surface proteins are required to anchor the polysaccharide matrix to the 
bacteria or to somehow link the polysaccharides together.  Cleavage of the protein anchors 
could, in this theoretical model, release the bacteria from the polysaccharide matrix and 
hence from the biofilm. 
 Dissolution of biofilms with proteinase K increased the sensitivities to both H2O2 
and lactic acid.  The finding that biofilm dispersal increases sensitivity suggests that an 
enzyme that specifically targets the biofilm structure could be therapeutically useful.  The 
use of probiotic therapy for BV, whereby healthy lactobacilli are re-introduced into the 
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vagina, has been proposed, and this study suggests that G. vaginalis would be more 
sensitive to probiotic therapy if it were planktonic (Reid 2001).  In addition to increasing 
the sensitivity of the bacteria to H2O2 and lactic acid, biofilm dissolution could increase the 
rate of explusion of the bacteria from the vagina by the natural flow of mucous.  Biofilm 
dispersal may also increase the susceptibility of the bacteria to the immune defenses.  
Proteinase K is a nonspecific protease that would likely damage the vaginal epithelium and 
would not be considered for clinical use.   
 We next tested the ability of four natural proteases to degrade the G. vaginalis 
biofilm.  The four fruit proteases, ficin, bromelain and papain, were effective biofilm 
degraders.  Papain produced a 75% reduction in biofilm mass at the lowest enzyme 
concentration used, 0.4 U, at both pH 7.4 and 4.5.  Although ficin produced an overall 
higher percentage of biofilm reduction, with 93 and 93% biofilm reduction at pH 7.4 and 
4.5, respectively, papain was used in the follow-up protease/antibiotic sensitivity assay due 
to its low cost and abundance in the laboratory.  Pepsin was a poor biofilm degrader; 
however, this is not surprising due to its limited activity in non-acidic environments.   
 Sensitivity assays using papain show that while 1.84 !g/ml of clindamycin led to a 
70% reduction in biofilm CFU, biofilms that had been pretreated with papain for 2 hours, 
then washed to remove nonadherent bacteria, had a 98% reduction in CFU counts.  Also, 
when papain and clindamycin were added to biofilms and incubated overnight, CFUs were 
reduced by 95%.  This suggests that treatment of patients with BV with both papain and an 
antibiotic, may increase the bacterial sensitivity to the antibiotic.  Although biofilm 
bacteria are more tolerant to antibiotics, as seen by the viability of 30% of the biofilm 
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bacteria, biofilms that have been dispersed by proteases such as papain, led to an almost 
100% eradication of biofilm bacteria; the few remaining planktonic bacteria may be more 
easily killed by the immune system.  More research is needed into the in vivo effects of the 
fruit proteases on the vaginal epithelium; the identification of an animal model would 
increase the knowledge of whether fruit proteases would be a valuable, harmless addition 
to antibiotic therarpy 
 This data suggests that a proteinaceous adhesin has an important role in biofilm 
formation in G. vaginalis.  Therapies aimed at disrupting this adhesin could prove 
extremely important in reducing the number of relapsing BV cases seen after antibiotic 
treatment.  The idea that bacteria can produce a biofilm matrix whose most important 
component is a protein is not new; however, the idea of targeting this protein in order to 
produce more effective anti-biofilm therapies is a recent one.  Lending precedence to the 
idea that BV may one day have an anti-biofilm therapy is the recently developed dispersal 
enzyme, Dispersin B, which is in the research phase at Walter Reed Army Institute of 
Research to analyze its efficacy in inhibiting or disrupting single- and mixed-species 
bacterial biofilms associated with combat trauma wound infections.  Although we have 
shown that G. vaginalis biofilms are able to be degraded by proteases suggesting a role for 
a proteinaceous adhesin, it is imperative to identify and characterize the gene(s) involved 
in biofilm formation. 
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CHAPTER 5 
 
Identification and Characterization of a Gardnerella vaginalis Biofilm-
Associated Protein 
 
 
 
Introduction 
Biofilms are communities of microorganisms that are surrounded by an 
extracellular polymeric matrix composed of polysaccharides, proteins and/or nucleic acids, 
which promote intercellular adhesion and attachment to a surface.  The biofilm mode of 
growth imparts on its constituent bacteria tolerance to antimicrobial agents, dessication, pH 
changes, ultraviolet light, acid exposure, phagocytosis and sheer stress (Lindsay and von 
Holy 2006; del Pozo and Patel 2007).   
 In most bacterial biofilms that have been characterized, the major intercellular 
adhesin holding the community together is an exopolysaccharide.  In the staphylococcal 
species, the biofilm matrix is composed of an extracellular polysaccharide homopolymer 
of #-1,6-linked N-acetylglucosamine (PNAG); this polymer is essential for biofilm 
formation and causes hemagglutination and bacterial aggregation (Heilmann, Schweitzer et 
al. 1996; Mack, Riedewald et al. 1999; Vuong, Voyich et al. 2004).  Many other bacteria 
can produce PNAG, including Acinetobacter baumanni and E. coli (Cerca and Jefferson 
2008; Choi, Slamti et al. 2009). Although many bacteria produce a polysaccharide based 
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biofilm matrix, others are able to produce biofilms cemented by proteins (Cucarella, 
Solano et al. 2001; Latasa, Roux et al. 2005; Branda, Chu et al. 2006; Loehfelm, Luke et 
al. 2008).  Henning et al. described a spontaneous switch from biofilm formation mediated 
by polysaccharides to biofilm formation mediated by proteins in a Staphylococcus 
epidermidis icaC insertion mutant (Hennig, Nyunt Wai et al. 2007).  In S. epidermidis, 
several surface proteins involved in biofilm formation have been described, including 
SSP1, SSP2 and the AtlE autolysin (Veenstra, Cremers et al. 1996; Heilmann, Hussain et 
al. 1997).  Other reports show that Staphylococcus sp. produce a protein adhesin named 
Bap, for biofilm-associated protein, which is involved in primary attachment and biofilm 
maturation (Cucarella, Solano et al. 2001).  Bap is a large, cell surface-associated protein 
containing a series of repeats that is found in isolates of several coagulase negative 
staphylococcal species, as well as S. aureus mastitis isolates (Cucarella, Solano et al. 
2001).  This protein falls within a family of surface proteins involved in biofilm formation, 
called biofilm-associated proteins, which are found on the bacterial surface, have a high 
molecular weight, and contain a core domain of tandem repeats (Lasa and Penades 2006).  
Other proteins found within this family include the newly identified Bap protein of 
Acinetobacter baumannii, the Esp protein of E. faecalis and the BapA protein of 
Salmonella sp. (Latasa, Roux et al. 2005; Tendolkar, Baghdayan et al. 2005; Loehfelm, 
Luke et al. 2008). 
We have demonstrated that compounds that degrade polysaccharide-based 
biofilms, such as sodium metaperiodate, have little effect on Gardnerella biofilms, while 
proteases are able to effectively degrade the biofilms (Patterson, Girerd et al. 2007).  This 
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suggests that a proteinaceous adhesin, like Bap, may mediate biofilm formation in G. 
vaginalis.  In this study, a partial genome sequence of G. vaginalis was analyzed for 
homology to the staphylococcal Bap protein.  This search identified a large hypothetical 
protein, with a core of internal repeating units, which we call BapL for Bap-like.  An 
antibody was produced against a small antigenic peptide of this protein and was used for 
inhibition of function assays.  It has also been shown that certain biofilm-associated 
proteins, like the enterococcal SgrA protein, can act as initial adhesins, binding to 
extracellular matrix proteins (Hendrickx, van Luit-Asbroek et al. 2009); therefore, the 
BapL protein was analyzed for its ability to bind to ECM proteins by blockage with the 
anti-bapL antibody.  Also, biofilm associated  proteins has been found to have homology 
to  mucus-binding protein; therefore, the BapL protein was also analyzed for its ability to 
bind to mucin.   
It has been shown that G. vaginalis adheres robustly to ME180 cervical epithelial 
cells (Patterson, Stull-Lane et al. 2010).  To help elucidate whether the BapL protein 
interacts with a component on the surface of ME180 epithelial cells, immunoprecipitation 
assays were performed.  Random mutagenesis was performed using the mutagen ethyl 
methanesulfonate (EMS) to produce a bapL deficient mutant, and finally, the BapL protein 
was expressed in the heterologous host S. aureus RN4220. 
  
Results 
Identification of a biofilm-associated protein   
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In order to identify new factors involved in biofilm formation, we searched a partial 
genome sequence of G. vaginalis, provided by the Gardnerella vaginalis Genome Project, 
Stanford Genome Technology Center (funded by the Ellison Medical Foundation) for 
sequence homology to the S. aureus Bap protein using the tBLASTn program provided by 
NCBI.  Our analysis revealed one incomplete open-reading frame encoding a hypothetical 
protein with significant similarity to Bap.  The identified gene encodes a protein of large 
size, with 9 Rib (resistance to proteases) domains, and 35% homology to the 
staphylococcal Bap protein, therefore, we have designated the gene BapL for Bap-like.  
Rib domains are found in group B streptococci and confer protective immunity to the 
bacteria (Stalhammar-Carlemalm, Stenberg et al. 1993).  The BapL protein also has 
homology to other known biofilm-associated proteins (Table 7).  Using Softberry’s 
FGENESB and BPROM programs, it was determined that the identified gene was missing 
the beginning of the open reading frame and promoter; therefore, we initiated genome 
walking experiments to identify the remainder of the gene.  The additional sequencing data 
found by genome walking was confirmed by pyrosequencing, which was performed at the 
VCU Nucleic Acids Core Laboratory using Roche 454 technology.  One full run of GS 
FLX and one half fun GS FLX XLR were done for G. vaginalis strain 5-1 (coverage of 
~175X).  The fully sequenced open reading frame is 9,144 base pairs and encodes a protein 
with a predicted molecular mass of 325 kDa.  Analysis of the amino acid sequence reveals 
a repetitive structure consistent with the Bap family of proteins, as well as a cell wall-
anchoring motif consistent with surface expression in Gram-positive organisms (Figure 
20). 
Organism Protein 
Similarity to 
Bap 
Similarity to 
BapL 
E. faecium Esp 38% 39% 
S. epidermidis Aap 71% 34% 
Salmonella sp. BapA 29% 34% 
A. baumanii Bap 33% 34% 
Table 7.  Homologies between the Bap protein of S. aureus and the 
BapL protein of G. vaginalis to other known biofilm-associated 
proteins. 
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Figure 20.  Structural schematic of the BapL protein from G. vaginalis 
compared to the Bap protein from S. aureus.  Both proteins are large, cell wall 
anchored surface proteins with tandem repeating units.  BapL is 325 kDa, contains 
9 Rib (resistance to proteases) domains which are associated with protective 
immunity, and 35% homology to the staphylococcal Bap protein. 
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The BapL protein is highly expressed under biofilm conditions 
In order to determine which conditions induce BapL expression, surface associated 
proteins were extracted from planktonic and biofilm cultures grown in BHI, as well as 
from biofilm cultures grown in BHIG.  Bacterial pellets were standardized by weight then 
proteins extracted.  The proteins were separated by SDS-PAGE, transferred to a PVDF 
membrane, and probed with purified polyclonal IgG rabbit antibodies raised against a 
small, antigenic peptide of BapL.  As shown in Figure 21, a band of approximately 325 
kDa is seen in the biofilm samples, while it is absent in the planktonic sample.  This 
suggests that BapL is more highly expressed under conditions that promote biofilm 
formation.  A biofilm grown in BHIG was treated with proteinase K to disrupt its biofilm 
structure and subjected to the same treatment to remove cell surface associated proteins.  
The absence of a BapL specific band in Figure 21 indicates that the BapL protein was 
removed by this proteinase K treatment.  The finding that proteinase K treatment disrupts 
biofilms and removes BapL from the surface suggests that BapL could possibly be 
involved in the biofilm structure.  
 
The bapL gene is highly expressed under biofilm conditions 
 We next analyzed the expression of the bapL gene under different conditions.  
Overnight cultures of G. vaginalis strain 5-1 were diluted in fresh BHI or BHIG in T75 
flasks and incubated anaerobically for 48 hours with fresh media change after 24 hours.  
Planktonic cultures of G. vaginalis were grown in 250 ml flasks of BHI anaerobically for 
48 hours with gentle stirring to keep the bacteria in the planktonic state.  Bacteria were  
Figure 21.  Western blot analysis of G. vaginalis proteins grown under different 
conditions.  G. vaginalis cultures were grown overnight as biofilms in BHI or 
BHIG and as planktonic cultures in sBHIs and BHIG.  Proteins were then extracted 
by sonication and loaded into each well.  Proteins were separated by SDS-PAGE, 
transferred to PVDF membrane and probed with anti-bapL antibodies.  Molecular 
mass standards are indicated in kilodaltons. 
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harvested and mRNA extracted.  Isolated mRNA was converted to cDNA using bapL and 
16S reverse primers and analyzed by real time reverse transcriptase PCR.  Expression of 
the bapL gene was normalized to 16s rRNA.  Figure 22 shows that expression of the bapL 
gene is highest in biofilms grown in BHI, whereas, expression is lowest in planktonic 
cultures.  Biofilms grown in BHI had two times more expression of bapL than biofilms 
grown in BHIG.  Planktonic expression of bapL was very low, with only a 0.0025 fold 
increase in bapL expression compared to expression of the 16S rRNA genes.  This data 
shows that the bapL gene is significantly upregulated under biofilm conditions. 
 
Anti-BapL antibody is specific and binds to the surface of G. vaginalis   
Confocal microscopy was used to determine whether the anti-BapL antibody was 
specific and if the BapL protein was surface associated.  Cultures of G. vaginalis and 
Lactococcus lactis, used as a negative control, were collected and washed with PBS then 
stained sequentially with purified anti-BapL antibody and labeled goat anti-rabbit 
secondary antibody.  Figure 23 shows that the anti-BapL antibody bound specifically only 
to Gardnerella bacteria, as demonstrated by the high fluorescence seen with addition of the 
anti-BapL antibody, while unrelated species, like Lactococcus lactis, showed no 
fluorescence with the addition of the anti-BapL antibody.  Binding of the antibody to the 
surface of G. vaginalis confirms that the BapL protein is surface associated.   
 
Anti-BapL antibody does not inhibit biofilm formation of G. vaginalis 
  
Figure 22.  The bapL gene is highly expressed in biofilm cultures.  Overnight 
cultures of G. vaginalis were diluted in fresh BHI or BHIG in T75 flasks.  
Planktonic cultures were grown in 250 ml flasks of BHI.  Each culture was grown 
anaerobically for 48 hours, either with media changer after 24 hours (biofilm only) 
or with gentle stirring (planktonic only).  Cultures were harvested by centrifugation 
to pellet cells and RNA from all cultures was extracted using a Fastpro RNA kit.  
Isolated RNA was DNase treated to ensure the absence of genomic DNA 
contamination and converted to cDNA using bapL and 16S reverse primers.  The 
bapL gene expression was then analyzed by reverse transcriptase PCR.  The 
absolute Ct values from 3 qPCR assays were averaged to determine the cycle 
threshold value from each sample.  Expression of bapL was normalized to 16s 
rRNA as determined by cycle threshold values using the following equation:  
E=2^(16s Ct – bapL Ct). 
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Figure 23.  Confocal microscopy confirms surface expression of BapL. Cultures 
of overnight G. vaginalis and Lactococcus lactis, which was used as a negative 
control, were pelleted and washed with PBS, then stained sequentially with the anti-
BapL Ab and  Alexa 488 labeled goat ant-rabbit antibody and analyzed by confocal 
microscopy. 
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            To determine if the BapL protein plays a role in biofilm formation by G. vaginalis, 
antibody inhibition assays were performed.  Overnight cultures of G. vaginalis were 
diluted 1:100 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator 
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody.  200 !l of 
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 24 hours.  
The wells were washed with PBS to remove nonadherent bacteria and stained with 
safranin, which imparts a red color to biofilms.  Figure 24 shows that bacteria treated with 
anti-BapL antibody and preimmune antibody formed biofilms that were no different from 
wildtype bacteria.  This shows that the addition of anti-BapL antibody was unable to 
inhibit biofilm of G. vaginalis. 
 
Anti-BapL antibody does not inhibit initial adherence of G. vaginalis 
 Because it has been shown that the staphylococcal Bap protein has roles in both 
primary attachment and biofilm maturation, we next analyzed whether the BapL protein 
was playing a role in initial adherence to a surface (Cucarella, Solano et al. 2001).  
Overnight cultures of G. vaginalis were diluted 1:50 in fresh BHIG and incubated for 30 
minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody or 
preimmune antibody.  200 !l of each culture was added to a 96-well plate, centrifuged to  
maximize interaction with the surface of the 96-well plate, and incubated anaerobically at 
37ºC for 2 hours.  After the 2 hour incubation, the wells were washed with PBS to remove 
nonadherent bacteria and stained with safranin.  Figure 25 shows that bacteria treated with 
anti-BapL antibody and preimmune antibody produced no significant difference in initial  
Figure 24.  Biofilm formation by G. vaginalis is not inhibited by addition of 
anti-BapL antibody.   An overnight culture of G. vaginalis was treated with either 
anti-BapL antibody or preimmune antibody for 30 minutes at room temperature on 
a rotator.  The culture was then plated and incubated anaerobically at 37ºC for 24 
hours.  Nonadherent cells were removed by washing with PBS and adherent 
bacteria were stained with safranin, which imparts a red color to biofilms.   
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Figure 25.  Initial adherence of G. vaginalis is not affected by the anti-BapL 
antibody.  An overnight culture of G. vaginalis was treated with either anti-BapL 
antibody or preimmune antibody for 30 minutes at room temperature on a rotator.  
The culture was then plated and incubated anaerobically at 37ºC for 2 hours.  
Nonadherent cells were removed by washing with PBS and adherent bacteria was 
stained with safranin, which imparts a red color to biofilms 
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adherence than wildtype bacteria.  This shows that the addition of anti-BapL antibody was 
unable to inhibit initial adherence of G. vaginalis.   
 
Anti-BapL antibody does not affect aggregation of G. vaginalis bacteria 
 Aggregation is an important ability of many bacteria and sometimes utilizes the 
same intercellular adhesins involved in biofilm formation (Schroeder, Jularic et al. 2009; 
Thompson, Abraham et al. 2010).  To analyze whether BapL was playing a role in 
aggregation, we again employed antibody inhibition.  Overnight cultures of G. vaginalis 
were standardized to ensure equal amounts of bacteria and either treated with PBS as a 
control, anti-BapL antibody or preimmune antibody.  The OD600 of the cultures was 
measured every 15 minutes for 120 minutes, and the measurements were plotted and 
slopes analyzed.  Slope values similar to the slope seen with wildtype bacteria would 
indicate the anti-BapL antibody had no effect on bacterial aggregation.  Figure 26 shows 
that the slope of the lines for wildtype bacterial aggregation, aggregation of bacteria treated 
with anti-BapL antibody and bacteria treated with preimmune antibody were similar, 
ranging from -0.0130 to -0.0134.  This data suggests that the anti-BapL antibody does not 
affect aggregation. 
 
Anti-BapL antibody does not affect G. vaginalis adherence to cervical epithelial cells 
 Because the anti-BapL antibody did not affect biofilm formation or initial 
adherence, we next tested whether the antibody could inhibit adherence of G. vaginalis to 
cervical epithelial cells.  Overnight cultures of G. vaginalis were incubated for 30 minutes  
Figure 26.  Aggregation of G. vaginalis is not affected by the anti-BapL 
antibody.  An overnight G. vaginalis culture was standardized to ensure equal 
numbers of bacteria and either treated with PBS as a control, anti-BapL antibody or 
preimmune antibody.  OD600 readings were taken ever 15 minutes for 120 minutes.  
The measurements were graphed, a line plotted and the slopes compared.  The 
slopes were similar, ranging from -0.0130 to -0.0134, indicating that addition of the 
antibodies did not affect aggregation. 
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at room temperature on a rotator with either 400 !g of anti-BapL antibody or 400 !g of 
preimmune antibody, standardized to ensure equal numbers of bacteria then added to 
confluent monolayers of ME180 cervical epithelial cells.  The plates were centrifuged to 
maximize interaction between the bacteria and epithelial cells and incubated at 37ºC for 15 
minutes in 5% CO2.  After the incubation, the wells were washed to remove nonadherent 
bacteria and harvested with addition of 5% saponin.  The bacteria were then diluted 10-
fold, plated on BPS plates and incubated for 48 hours, before plates were analyzed and 
colonies counted.  Figure 27A shows the percent adherence for wildtype G. vaginalis, G. 
vaginalis treated with 1:20 BapL antibody and G. vaginalis treated with 1:20 preimmune 
antibody.  Addition of anti-BapL antibody did not significantly affect adherence of the 
bacteria to cervical epithelial cells.  Although the percent adherence of G. vaginalis treated 
with preimmune antibody was relatively lower than either the wildtype bacteria or bacteria 
treated with anti-BapL antibody, this could have been due to clumping of the bacteria 
during plating.  Adherence was also analyzed by confocal microscopy (Figure 27B) and it 
was seen that adherence did not differ significantly between wildtype G. vaginalis and 
Gardnerella treated with anti-BapL antibody or preimmune antibody.  However, when G. 
vaginalis was pretreated with proteinase K prior to the adherence assay, the bacteria were 
unable to adhere to the cervical epithelial cells (Figure 28).  This suggests that G. 
vaginalis may utilize a cell wall-anchored protein, potentially the BapL protein, for 
adherence to cervical epithelial cells 
 
Anti-BapL antibody does not affect G. vaginalis interaction with ECM proteins 
Figure 27.  Adherence of G. vaginalis to cervical epithelial cells is not affected 
by addition of anti-BapL antibody.  Adherence of wildtype G. vaginalis, bacteria 
treated with anti-BapL antibodies and bacteria treated with preimmune antibodies 
was compared.  (A)  Percent adherence calculated from CFUs and (B) Confocal 
images of adherence. 
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Figure 28.  Adherence of proteinase K treated G. vaginalis to cervical epithelial 
cells.  Bacteria were grown in sBHIG anaerobically at 37 °C for 24 hrs.  G. 
vaginalis was first treated with 20 !g/ml of proteinase K for an hour, pelleted and 
washed to remove residual enzyme.  Bacteria (green) were standardized to ensure 
equal numbers, added to vaginal epithelial cells (red) and incubated for 15 minutes 
before washing to remove nonadherent bacteria.  Qualitative estimates of adherence 
were ascertained by confocal microscopy 
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 A surface adhesin, SgrA, involved in biofilm formation in hospital-acquired 
Enterococcus faecium strains, has recently been shown to play a role in binding to 
extracellular matrix molecules nidogen 1, nidogen 2 and fibrinogen (Hendrickx, van Luit-
Asbroek et al. 2009).  Perhaps the G. vaginalis BapL protein is acting as a microbial 
surface component recognizing adhesive matrix molecules (MSCRAMM), allowing the 
bacteria to interact with extracellular matrix molecular like fibrinogen or fibronectin.  To 
test this, overnight cultures of G. vaginalis were diluted 1:10 in PBS and incubated for 30 
minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody or 400 
!g of preimmune antibody.  200 !l of each culture was added to a 96-well plate that had 
been previously incubated and immobilized with the ECM proteins fibronectin, fibrinogen, 
hyuluronic acid, elastin, and collegan IV.  The plates were centrifuged to maximize 
interaction between the bacteria and ECM proteins then incubated at 37ºC for 10 minutes.  
After the 10 minute incubation, the wells were washed to remove nonadherent bacteria 
then stained with safranin to ascertain the interaction between bacteria and ECM proteins.  
Figure 29 is an image of the scanned 96-well plate with G. vaginalis allowed to interact 
with the ECM proteins.  No difference is seen between wildtype G. vaginalis and G. 
vaginalis treated with the anti-BapL antibody or preimmune antibody.  This data suggests  
that the anti-BapL antibody is unable to inhibit interaction of G. vaginalis with ECM 
proteins. 
  
Adherence of G. vaginalis to mucus is not affected by the anti-BapL antibody 
Figure 29.  Adherence of G. vaginalis to ECM proteins is not affected by the 
anti-BapL antibody.    Overnight  cultures of G. vaginalis were diluted 1:10 in 
PBS and incubated for 30 minutes at room temperature on a rotator with either 
400 !g of anti-BapL antibody or preimmune antibody.  200 !l of each culture 
was added to a 96 well plate that had been precoated with ECM proteins.  The 
plates were centrifuged, incubated, wells washed and stained with safranin .  
Red color indicates attached bacterial cells. 
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 Homology searches show that the BapL protein has homology to the Lactobacillus 
fermentum protein Mlp, which in turn is similar to the mucus binding protein, Mub, from 
Lactobacillus reuteri (Roos and Jonsson 2002; Turner, Hafner et al. 2003).  The Mub 
protein is a 358 kDa protein with 14 approximately 200 amino acid repeats and features 
typical of other cell surface proteins of Gram positive bacteria (Roos and Jonsson 2002).  
We next analyzed whether the BapL protein was playing a role in mucus binding activity 
of G. vaginalis.  Overnight cultures of G. vaginalis were diluted 1:10 in PBS and incubated 
for 30 minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody 
or 400 !g of preimmune antibody.  200 !l of each culture was added to a 96-well plate that 
had been previously incubated and immobilized with mucin.  The plate was centrifuged to 
maximize interaction between the bacteria and mucin then incubated at 37ºC for 10 
minutes.  After the 10 minute incubation, the wells were washed to remove nonadherent 
bacteria then stained with safranin to ascertain the interaction between bacteria and mucin.  
Figure 30A demonstrates that there was no difference in mucus binding ability between 
wildtype G. vaginalis and G. vaginalis treated with anti-BapL antibody or preimmune 
antibody, suggesting that the anti-BapL antibody is unable to inhibit interaction of G. 
vaginalis with mucus.    A mucin dot blot utilizing 5% and 1% dilutions of mucin on a 
nitrocellulose membrane, probed with purified surface proteins from G. vaginalis 
demonstrates that the BapL protein is not binding to porcine mucin (Figure 30B).   
Figure 30.  Adherence of G. vaginalis to mucus is not affected by the anti-BapL 
antibody.  (A) Overnight  cultures of G. vaginalis were diluted 1:10 in PBS and 
incubated for 30 minutes at room temperature on a rotator with either 400 !g of 
anti-BapL antibody or preimmune antibody.  200 !l of each culture was added to a 
96 well plate that had been precoated with mucin.  The plate was centrifuged, 
incubated, wells washed and stained with safranin.  Red color indicates attached 
bacterial cells.  (B) Mucin dot blot of adherence of G. vaginalis proteins. 
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Opsonophagocytosis assays demonstrate that the anti-BapL antibody acts as an 
effective opsonin.   
 We compared phagocyte killing by the anti-BapL antibody and preimmune 
antibody for biofilm and dispersed biofim cultures of G. vaginalis.  It is known that biofilm 
bacteria exhibit increased resistance to phagocytosis; therefore, we hypothesized that the 
percent killing seen with biofilm bacteria compared to dispersed biofilm bacteria would be 
low.  Figure 31 shows that 100% of biofilm bacteria survived when leukocytes, 
preimmune antibody, and complement were added; however, 26.3% of biofilm bacteria 
were killed when preimmune antibody was replaced with the anti-BapL antibody.  In 
contrast, dispersed biofilm bacteria were rapidly killed by leukocytes when the anti-BapL 
antibody was added (97% killing).  This data suggests that dispersed biofilm G. vaginalis 
bacteria are more sensitive to opsonophagocytosis and the anti-BapL antibody is acting as 
an effective opsonin.   
 
Far Western analysis failed to demonstrate an interaction between BapL and ME180 
cervical epithelial protein 
Since we demonstrated that G. vaginalis adheres robustly to ME180 cervical 
epithelial cells, we analyzed whether the BapL protein was interacting with a structure on 
the surface of the cervical epithelial cells.  Proteins were extracted from confluent 
monolayers of ME180 cervical epithelial cells and separated by SDS-PAGE.  The gels 
were then transferred to PVDF membrane and incubated with surface proteins that had 
been purified from G. vaginalis by sonication.  The membranes were then washed, probed  
Figure 31.  Opsonophagocytic activity of anti-BapL antibody and preimmune 
antibody against biofilm and dispersed biofilm cultures of G. vaginalis.  G. 
vaginalis biofilms were grown on glass beads.  Glass beads were sonicated for 10 
sec to produce dispersed biofilm cultures.  Cultures were subjected to 
opsonophagocytic assays utilizing leukocytes, baby bunny complement and either 
anti-BapL antibody or preimmune antibody.  The assays were incubated for 90 mins 
then dilution plated for CFU counts.  Percent killing was determined as described in 
the text.   
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with anti-BapL antibody followed by HRP-labeled goat anti-rabbit antibody, and analyzed 
by film.  Figure 32A shows three membranes, one which was probed with G. vaginalis 
proteins and anti-BapL antibody, the second was probed with G. vaginalis proteins and 
preimmune antibody and the third was an antibody control membrane only probed by the 
anti-BapL antibody.  A 23 kDa band is seen on the membrane probed with G. vaginalis 
proteins with the anti-BapL antibody; however, the exact same band is seen in the antibody 
control membrane which was not probed with G. vaginalis proteins.  This suggests that the 
anti-BapL antibody is binding nonspecifically to a ME180 cervical epithelial cell protein. 
 To confirm these results, we continued with an immunoprecipitation assay utilizing 
the anti-BapL antibody coupled to a protein G column to pull-down BapL-ME180 protein 
complexes.  Anti-BapL antibody was coupled to protein G beads and allowed to incubate  
with 10 mg of G. vaginalis surface proteins and 10 mg of ME180 cervical epithelial cell 
proteins.  After a two hour incubation, the mixture was placed in a column and washed 4X 
with PBS.  The bound proteins were eluted by addition of 0.2M Glycine/HCl pH 2.5 and 
neutralized with 1M Tris/HCl pH 9.0.  The proteins were separated by SDS-PAGE and the 
gel stained with Imperial protein reagent to visualize proteins.  Figure 32B shows the 
immunoprecipitated proteins; only the 23 kDa cervical epithelial cell protein and a few 
contaminating proteins are seen on the gel, the 325 kDa BapL protein is missing.  This 
suggests that the 23 kDa protein is actually interacting nonspecifically with the anti-BapL 
antibody and is not interacting with the BapL protein. 
Figure 32.  Immunoprecipitation assays demonstrate that the anti-BapL 
antibody, not BapL, interacts with a ME180 cervical epithelial protein.  Me180 
cervical epithelial proteins were harvested and separated by SDS-PAGE.  The gel 
was transferred to PVDF membrane and incubated with surface proteins from G. 
vaginalis.  The membrane was probed with either anti-BapL antibody or 
preimmune Ab.  (A)  PVDF membrane  incubated with G. vaginalis proteins probed 
with anti-BapL antibody, membrane incubated with G. vaginalis proteins probed 
with preimmune antibody or membrane incubated with no protein and probed with 
anti-BapL antibody as a control.  (B) Anti-BapL antibody was coupled to a protein 
G column and 10 mg of G. vaginalis surface proteins and 10 mg of ME180 cervical 
epithelial cell protein were ran onto column, bound proteins were eluted by 0.2M 
Glycine/HCl pH 2.5.  Eluted proteins were separated by SDS-PAGE and the gel 
was stained overnight with Imperial protein stain.  Arrow indicates the  
approximatedly 23 kDa protein that interacts nonspecifically with the anti-BapL 
antibody. 
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EMS mutagenesis did not produce a bapL mutant of G. vaginalis 
 Since no genetic system is available in G. vaginalis, we utilized random 
mutagenesis in order to produce a bapL mutant.  Ethyl methanesulfonate or EMS is a 
mutagenic, teratogenic and possibly carcinogenic organic compound that produces random 
mutations in genetic material by nucleotide substitution.  EMS reacts with guanine in 
DNA, forming 0-6-ethylguanine, which impairs the ability of DNA polymerase to 
accurately incorporate a cytosine opposite of guanine.  An EMS kill curve was performed 
and 50 !l of EMS for 30 minutes was found to kill 90% of G. vaginalis.  This amount of 
EMS and 30 minutes was used to mutate G. vaginalis.  The mutagenized G. vaginalis 
culture was allowed to recover for 48 hours in BHIG before being stained with anti-BapL 
antibody and an Alexa-488 labeled goat anti-rabbit secondary antibody.  These stained 
bacteria were then sorted by fluorescence activated cell sorting (FACS) and low 
fluorescent intensity bacteria were collected.  The bacteria with low fluorescence intensity 
could potentially have a defect in the bapL gene, producing fewer BapL proteins on the 
surface of the bacteria and thereby causing a lower amount of fluorescence intensity due to 
a lower amount of anti-BapL antibody binding.  Bacteria with the lowest fluorescence 
intensity were collected in individual wells of a 96-well plate and allowed to incubate 
anaerobically for 48 hours at 37°C.   
 Approximately 20 potential G. vaginalis mutants were found after the 48 hour 
incubation.  Because we hypothesized that BapL may be playing a role in biofilm 
formation, we utilized biofilm assays to determine if any of the 20 potential mutants had a 
defect in biofilm formation.  Unfortunately, no defect in biofilm formation was seen in any 
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of the potential mutants tested.  Western blot analysis of surface proteins from each of the 
potential mutants was also inconclusive, in that no mutant was definitively BapL negative.  
These experiments should be repeated, since thousands of potential mutants would need to 
be screened in order to cover the whole G. vaginalis genome. 
 
Heterologous expression of BapL in S. aureus caused an increase in biofilm formation 
but this was found to be due to an increase in PNAG production 
 Finally, the bapL gene was cloned into the E. coli/S. aureus shuttle vector pRB473 
for heterologous expression in the poor-biofilm producing strain of S. aureus RN4220.  
The bapL gene was PCR amplified using the primers BapSbfFWD and BapSbfReV, which 
had been designed from previous sequence analysis to introduce Sbf1 restriction sites on 
either end of the gene.  The PCR product was subcloned into the plasmid pCR2.1®Topo to 
construct the recombinant plasmid pCR2.1-Topo-bapL.  This plasmid was used to 
transform CH3 blue chemically competent E. coli cells, resultant colonies were pooled and 
plasmid purified, and plasmid was digested with Sfb1 to drop out the bapL PCR product.  
This digested bapL PCR product was then ligated into Pst1-linearized E. coli/S. aureus 
shuttle vector pRB473, producing plasmid pRB473-bapL, and used to transform CH3 blue 
chemically competent E. coli.  Plasmid was purified from individual E. coli transformants 
and screened for correct insert by digestion with Pst1.  Plasmid with correct insert size was 
used to transform S. aureus strain RN4220, producing strain RN4220-bapL.    
 Strain RN4220-bapL and RN4220 with empty pRB473 were analyzed for their 
ability to form a biofilm.  Figure 33 shows the biofilms produced by strain RN4220-bapL  
Figure 33.  Heterologous expression of BapL in S. aureus RN4220 caused an 
increase in biofilm formation.  The bapL gene was PCR amplified and cloned into 
the E. coli/S. aureus shuttle vector pRB473.  Plasmid pRB473-bapL and empty 
vector were transformed into S. aureus RN4220, which is a poor-biofilm producing 
strain, by electroporation.  Cultures were grown in LB + 1% glucose, BHI + 1% 
glucose and TSB + 1% glucose and analyzed for biofilm formation by washing and 
staining with safranin. 
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and empty vector under different media conditions. S. aureus RN4220-bapL was able to 
produce a thicker biofilm than RN4220 with empty vector under the media conditions 
tested, producing a 2.8 fold increase in biofilm in LB + 1% glucose, a 2.2 fold increase in 
biofilm in BHI + 1% glucose and a 7.3 fold increase in TSB + 1% glucose.   
 S. aureus has a very efficient stress response system; therefore, expression of 
foreign proteins can upregulate production of PNAG.  To ensure that the introduction of 
the bapL gene had not led to upregulation of PNAG production, a dot blot assay for PNAG 
was employed.  Standardized amounts of overnight cultures of RN4220-bapL and empty 
vector were centrifuged to pellet the cells and resuspended in 0.5 M EDTA.  The samples 
were boiled, supernatants diluted, and blotted onto nitrocellulose membrane.  The 
membranes were then dried, blocked with BSA, and probed with anti-PNAG antibody 
followed by ant-goat HRP-labeled secondary antibody.  Figure 34 shows the PNAG dot 
blot of two colonies of RN4220-bapL and RN4220 with empty vector; bacteria harboring 
the plasmid pRB473-bapL had a significant increase in production of PNAG compared to 
bacteria with empty vector.  This suggests that the increase in biofilm formation seen in 
bacteria with pRB473-bapL is due to an increase in PNAG production and is not directly 
related to production of the BapL protein.    
To circumvent this problem of increased production of PNAG, the pRB473-bapL 
plasmid was transduced into S. aureus strain RN4220!ica, which is deficient in the genes 
required to produce PNAG.  Biofilm formation was then assessed without the interference 
of increased production of PNAG.  Figure 35 shows the biofilms produced by 
RN4220!ica with pRB473-bapL and empty vector in different media conditions.  No  
Figure 34.  Dot blot analysis of PNAG production by wildtype S. aureus 
RN4220 and S. aureus RN4220-bapL and empty vector.  Overnight cultures of 
RN4220, RN4220-bapL and RN4220 empty vector were centrifuged to pellet the 
cells and resuspended in 0.5 M EDTA.  The samples were boiled to extract PNAG, 
diluted and blotted onto a nitrocellulose membrane.  The membranes were probed 
with anti-PNAG antibody and HRP-labeled secondary antibody before being 
analyzed by x-ray film. 
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Figure 35. Heterologous expression of BapL in a PNAG negative strain did not 
cause an increase in biofilm formation.  The bapL gene was PCR amplified and 
cloned into the E. coli/S. aureus shuttle vector pRB473.  Plasmid pRB473-bapL and 
empty vector were transduced into S. aureus RN4220!ica, which is deficient in the 
genes required to produce PNAG.  Cultures were grown in TSB + 1% glucose, 12.5 
mM calcium, 12.5 mM EGTA and 3.25% NaCl and BHI + 1% glucose, 12.5 mM 
calcium, 12.5 mM EGTA and 3.25% Nacl and analyzed for biofilm formation by 
washing and staining with safranin. 
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significant difference is seen between the biofilms produced by the bacteria with pRB473-
bapL or empty vector in any of the eight media conditions tested.  This could be suggestive 
of a few things: the BapL protein may not be surface exposed or functional in the 
heterologous host, the protein may not be translated in the host, the BapL protein may not 
be important in biofilm formation or it may need to act in concert with other proteins, like 
pilin, to produce biofilm.   
 In order to elucidate the function of the BapL protein, heterologous expression was 
attempted in a number of different organisms, including Bifidobacterium longum, which is 
the closest known relative of G. vaginalis, Lactococcus lactis and Bacillus subtilis.  
Unfortunately, technical limitations related to the very large size of BapL prevented 
expression in the other host strains. 
 
Discussion  
 Recently, Swidsinski et al. found that G. vaginalis is able to form an adherent 
biofilm on the vaginal epithelium of women with BV and that this biofilm may contribute 
to the pathogenesis and recurrence of BV (Swidsinski, Mendling et al. 2005).  Supporting 
the argument that the biofilm phenotype of Gardnerella leads to the recurrence seen with 
BV are the follow-up papers by Swidsinski et al. and Patterson et al. that observed a 
resurgence of a dense an active bacterial biofilm consisting primarily of G. vaginalis after 
cessation of treatment and biofilms of G. vaginalis were resistant to high amounts of lactic 
acid and hydrogen peroxide (Patterson, Girerd et al. 2007; Swidsinski, Mendling et al. 
2008).  It has also been shown that G. vaginalis produces a number of virulence properties, 
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including the ability to form a biofilm, produce cytotoxic changes to mammalian cells and 
adhere to vaginal epithelial cells, that many of the other BV-associated organisms do not 
possess; this lends precedence to the theory that G. vaginalis may be the most important 
organism in the pathogenesis of BV.  We choose to study biofilm formation by G. 
vaginalis in order to better understand the bacteria’s role in BV and improve available 
treatment methods. 
 We identified a protein in G. vaginalis that has significant homology to the BAP 
(biofilm-associated protein) family of proteins.  The first member of the BAP family to be 
described was found in Staphylococcus aureus and many have since been described in a 
number of other pathogenic bacteria, including Salmonella sp., Enterococcus sp, and most 
recently Acinetobacter baumannii (Cucarella, Solano et al. 2001; Toledo-Arana, Valle et 
al. 2001; Latasa, Roux et al. 2005; Latasa, Solano et al. 2006; Loehfelm, Luke et al. 2008).  
All BAP proteins are high molecular weight, surface proteins with a core of internal 
repeats involved in biofilm formation (Latasa, Solano et al. 2006).  The staphylococcal 
Bap protein is involved in primary attachment of the bacteria to a surface, biofilm 
maturation, and production of a persistant infection (Cucarella, Solano et al. 2001; Latasa, 
Solano et al. 2006).   
 The newly identified G. vaginalis protein, which we call BapL for Bap-like, is a 
high molecular weight protein, with a predicted molecular mass of 325 kDa.  It is a highly 
repetitive protein, with multiple copies of repeat domains.  We hypothesize that the 
extensive repeat region seen in the G. vaginalis BapL protein could serve to promote 
interactions between the protein and abiotic surfaces or with other BapL proteins on 
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neighboring bacteria, thus leading to biofilm formation and maturation.  The BapL protein 
is exposed on the surface of G. vaginalis, as seen by confocal microscopy and western blot 
analysis.  This is consistent with the sequencing data, which shows that the BapL protein 
has a carboxy-terminal segment containing an LPxTG motif, which is typical of cell wall-
anchored surface proteins in gram-positive bacteria (Navarre and Schneewind 1994).  The 
bapL gene is also highly expressed in biofilm cultures, as analyzed by reverse-transcriptase 
PCR.   
 An antibody was generated in rabbits against a small, antigenic peptide of the BapL 
protein.  This antibody was utilized in antibody inhibition assays against biofilm 
formation, initial adherence, adherence to cervical epithelial cells, and adherence to ECM 
proteins and mucin.  However, the anti-BapL antibody was unable to inhibit any of these 
properties of G. vaginalis.  This does not conclusively demonstrate that BapL is not 
involved in any of these properties.  The antibody was designed against a small, antigenic 
peptide of the BapL protein and it therefore may bind in such a way that it does not inhibit 
the active site of the protein thereby making the antibody inefficient in inhibiting the role 
of BapL or perhaps there is redundancy within the BapL protein and other sites on the 
protein can be used to elicit a function.   Another reason why the anti-BapL antibody may 
not block biofilm formation is that there may be other proteins, carbohydrates or nucleic 
acids involved in biofilm formation that the anti-BapL antibody is unable to block. 
 Next, we analyzed whether the BapL protein was interacting with a receptor on the 
surface of ME180 cervical epithelial cells to cause adherence.  ME180 cervical epithelial 
cell proteins were separated and transferred to a PVDF membrane and incubated with G. 
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vaginalis surface proteins.  Upon film exposure, a 23 kDa protein was visible on the 
membrane incubated with G. vaginalis proteins and probed with anti-BapL antibody.  
Unfortunately, the control membrane, which was not incubated with protein but was 
probed with anti-BapL antibody, also showed that 23 kDa protein.  This suggests that the 
anti-BapL antibody interacts nonspecifically with a ME180 cervical epithelial cell protein.  
However, this does not rule out the fact that BapL could be interacting with a ME180 
cervical epithelial cell protein; perhaps the BapL protein has become nonfunctional during 
the purification process and is unable to bind to is receptor or the receptor did not retain 
fuction after electrophoresis and electroblotting. 
 To further elucidate whether the BapL protein was interacting with a receptor on 
the surface of ME180 cervical epithelial cells, immunoprecipitation assays were 
conducted.  Anti-BapL antibody was coupled to protein G beads and used to pull down 
BapL:ME180 protein complexes.  The protein was eluted from the column, separated by 
SDS-PAGE and stained overnight to visualize proteins.  Outside of a few contaminanting 
proteins, the only relevant protein on the gel was the 23 kDa protein that interacts 
nonspecifically with the anti-BapL antibody; no BapL protein was seen on the gel.  This 
suggests that the BapL protein may not be the protein that allows for adherence of G. 
vaginalis to ME180 cervical epithelial cells. 
 When EMS was used to mutagenize the G. vaginalis genome, no bapL mutants 
were found.  However, this could be due to the limited numbers of mutants that have been 
screened or analysis of a phenotype that is not associated with inactivation of the bapL 
gene.  Although there are many possible pitfalls associated with producing a mutant using 
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EMS, it is the most efficient mechanism of obtaining mutant bacteria when a genetic 
system is lacking. 
 Finally, the BapL protein was expressed in a heterologous host and the host was 
analyzed for biofilm formation.  Introduction of a plasmid carrying the bapL gene caused 
an increase in PNAG production in the S. aureus heterologous host RN4220.  When the 
plasmid was moved into the PNAG deficient strain, S. aureus RN4220!ica, no difference 
was seen between biofilm formation in the bacteria harboring bapL versus empty vector.  
This could mean that BapL plays no role in biofilm formation or that the protein is not 
being expressed functionally in the heterologous host.  Equally likely other components 
like carbohydrates or nucleic acid might be necessary to produce biofilm, and if not 
supplied by the heterologous host, no increase in biofilm formation would be seen with the 
addition of just the BapL protein.  It has been shown in Salmonella sp. that curli, cellulose 
and the cell surface protein BapA play a role in biofilm formation;  deletion of BapA 
caused a loss of the capacity to form a biofilm, however, overproduction of curli could 
compensate for the biofilm deficiency in the bapA mutant strain (Latasa, Roux et al. 2005; 
Jonas, Tomenius et al. 2007).  It is known that G. vaginalis produces pili; perhaps pili play 
a role in biofilm formation along with the BapL protein (Johnson and Davies 1984; 
Boustouller, Johnson et al. 1987).  Without a more advanced genetic system, like plasmids 
or a transformation protocol for G. vaginalis, the exact role of BapL may not be known for 
some time. 
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CHAPTER 6 
 
Conclusions and Clinical Relevance 
 
 
 
This work was designed to elucidate the virulence properties of G. vaginalis in an 
effort to better understand the pathogenesis of BV and improve current therapies.  BV is of 
particular clinical relevance due to its propensity to increase transmission and acquisition 
of the HIV retrovirus and cause numerous pregnancy complications.  These studies have 
addressed basic questions relating to the virulence potential of G. vaginalis and its ability 
to form a biofilm.  Although it was known that G. vaginalis was able to form a biofilm on 
the vaginal epithelium of women with BV, nothing was known about the components of 
the biofilm matrix or what gene(s) could be involved in formation of the biofilm. 
To help elucidate the role of G. vaginalis in BV, the virulence potential of G. 
vaginalis and other BV-associated anaerobes were compared.  It was shown that G. 
vaginalis is able to form a thick, adherent biofilm, cause cytotoxicity and adhere robustly 
to vaginal epithelial cells (Patterson, Stull-Lane et al. 2010).  The other BV-associated 
anaerobes tested had one of the virulence properties, but none had the ability to produce all 
three virulence properties.  Surprisingly, only Peptoniphilus sp. bacteria were able to 
adhere to vaginal epithelial cells in a manner similar to G. vaginalis; although, 
Peptoniphilus adhered more homogenously to the vaginal cells whereas G. vaginalis 
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adhered as large clusters.  This is the first record of the ability of Peptoniphilus to adhere 
to vaginal epithelial cells and this data warrants more research into the role Peptoniphilus 
plays in BV.  
G. vaginalis has also been found to produce a pore-forming toxin called 
vaginolysin (Gelber, Aguilar et al. 2008).  Our research has shown that vaginolysin 
requires direct contact with epithelial cells to exert its activity.  There is precedence in the 
literature for cholesterol-dependent cytolysins, like vaginolysin, to be injected directly into 
host cells.  It has been found that the Gram-positive pathogen Streptococcus pyogenes 
utilizes a type III secretion-like system called cytolysin-mediated translocation for 
injection of effector proteins into the host cell (Madden, Ruiz et al. 2001).  Perhaps G. 
vaginalis is capable of cytolysin-mediated translocation; our data support a model in which 
vaginolysin is translocated into the host cell membrane via direct contact between bacteria 
and host cell.  We hypothesize that once vaginolysin has produced a pore in the host cell 
membrane, effector proteins could be passed into the host cell through the vaginolysin pore 
and vaginolysin and the effector proteins could act synergistically to trigger cytotoxicity. 
One of the most important virulence properties that G. vaginalis possesses is its 
ability to form a thick, tenacious biofilm.  Biochemical characterization of the G. vaginalis 
biofilm matrix demonstrates an increase in carbohydrate content compared to planktonic 
cultures.  Lectin blots, which utilize sugar-binding proteins that are highly specific for their 
sugar moieties, show that wheat germ agglutinin, which binds to N-acetylglucosamine, 
binds to biofilm extracts.  This suggests that N-acetylglucoasmine is a major component of 
the biofilm matrix.    However, when compounds that are able to degrade N-
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acetylglucoasmine, like sodium metaperidoate, were used in degradation assays, the 
compound was unable to degrade G. vaginalis biofilms.  This suggests that although the 
polysaccharide is a major constituent of the biofilm matrix, it is not the most important 
component of the biofilm in regards to structure and architecture. Other degradation assays 
utilizing the proteases, proteinase K and trypsin, show that the G. vaginalis biofilm is able 
to be degraded by proteolytic enzymes, suggesting that a proteinaceous adhesin is involved 
in biofilm formation in G. vaginalis.  This is very important data in BV research because 
up until this point, nothing was known about the G. vaginalis biofilm.  This data points to a 
new avenue of therapeutic research; an enzyme that specifically targets the biofilm matrix 
of G. vaginalis may prove a valuable addition to current antibiotic therapy. 
Sensitivity assays demonstrated that G. vaginalis biofilms were more resistant to 
lactobacilli derived compounds and tolerated 4-fold higher concentrations of hydrogen 
peroxide and 8-fold higher concentrations of lactic acid than planktonic cultures.  
However, when the biofilm was degraded with proteinase K, this increased the 
susceptibility of the bacteria to hydrogen peroxide and lactic acid to planktonic levels.  
This alludes to the fact that BV may be better treated if the G. vaginalis bacteria are in the 
planktonic mode of growth rather than the biofilm mode of growth.  A good adjuvant to 
antibiotic therapy would be an enzyme that could reduce biofilm mass down to its 
planktonic component before addition of the antibiotic.  
Natural proteases were also analyzed for their ability to degrade G. vaginalis 
biofilms.  The three fruit proteases, bromelain, papain and ficin, proved to be effective 
biofilm degraders.  We hypothesize that natural proteases, like the fruit proteases tested, 
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could have the ability to degrade the G. vaginalis biofilm without overly affecting the 
vaginal epithelial cells.  When papain was used to disperse the biofilm, it increased killing 
by clindamycin to 95%; without first dispersing the biofilm, only 70% of the bacteria were 
killed by an MIC 3 times the amount needed to kill planktonic bacteria.  Perhaps, papain 
will eventually be used in combination with antibiotic therapy to reduce the relapse seen 
with BV.  Future experiments should analyze the effect of the natural proteases on vaginal 
biopsies from women with or without BV.   
Since it has been seen that many bacteria which produce a protein-based biofilm 
matrix utilize a family of proteins called biofilm-associated proteins or BAP, we searched 
a partial genome sequence of G. vaginalis for sequence homology to the most well 
characterized BAP, the staphylococcal Bap protein.  Our analysis revealed an open-reading 
frame encoding a hypothetical protein which was of large size and contained a core of 
tandem repeating units.  The protein had 35% homology to the staphylococcal Bap protein 
and although this does not seem like high sequence homology, the presence of other 
similar characteristics, like the large size and repeating units, make it highly likely that the 
hypothetical protein falls within the family of BAP proteins.  The bapL gene is also highly 
expressed under biofilm conditions.  Due to the protein’s similarity to the staphylococcal 
protein and its expression in biofilm cultures, we have called the protein BapL for Bap-
like. 
Because the BapL protein is so large, 325 kDa, it was unrealistic to try and purify 
the whole protein from E. coli and use this to immunize rabbits for production of the anti-
BapL antibody.  Therefore, antibody was developed against a small, antigenic peptide of 
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the BapL protein.  This antibody was used in western blot analysis of the expression of the 
BapL protein under different conditions; it was found that BapL is more highly expressed 
under the biofilm mode of growth than under planktonic conditions.  The antibody was 
also used for confocal microscopy which confirmed surface expression of the BapL protein 
and antibiotic specificity at the species level.   
Antibody inhibition assays were performed to identify the function of the BapL 
protein.  However, the antibody failed to inhibit biofilm formation, initial adherence, 
aggregation, adherence to cervical epithelial cells, and adherence of the bacteria to ECM 
proteins and mucin.  Since only a small, antigenic section of the BapL protein was used to 
produce antibodies, it could have produced an antibody that was able to interaction with 
the BapL protein, as seen in the western blot and confocal microscopy data, but failed to 
interact in such a way that it blocked the active site of the protein, thereby, allowing for 
continued function when the antibody was bound.  However, the data could also suggest 
that the BapL protein is not involved in the functions tested or the protein is required but 
needs other components to fulfill its function.  This could be analyzed by producing mutant 
bacteria lacking the BapL protein and other components, like carbohydrates or pilin, and 
testing their ability to produce a biofilm, adhere, etc.  Since no genetic system is available 
for G. vaginalis, employment of random mutagenesis with a DNA mutatgen like EMS 
could potentially produce a bapL mutant.  Although we did not find a bapL mutant using 
EMS mutagenesis, this could be due to the limited number of potential mutants that were 
screened. 
  184 
Since we had seen that G. vaginalis adheres robustly to ME180 cervical epithelial 
cells, we hypothesized that the BapL protein may be playing a role in this adherence.  To 
test this, a sandwich western blot approach was taken.  ME180 cervical epithelial cells 
were separated by SDS-PAGE, transferred to PVDF membrane and probed with purified 
surface proteins from G. vaginalis.  If the BapL protein was able to interact with a protein 
on the surface of the ME180 cervical epithelial cells, it should be able to bind to that band 
on the PVDF membrane.  When probed with the anti-BapL antibody, the ME180 
protein:BapL complex should be visible on x-ray film.  A 23 kDa protein was seen when 
the ME180 protein PVDF membrane was probed with purified surface proteins from G. 
vaginalis; however, the same band was seen in an antibody control membrane.  This 
suggests that the anti-BapL antibody is interacting with a ME180 protein.  This data does 
not rule out the hypothesis that the BapL protein is interacting with a receptor on the 
surface of the ME180 cervical epithelial cells.  Perhaps during purification of the surface 
proteins of G. vaginalis, the BapL protein becomes inactivated or denatured; this would 
inhibit binding of the protein to its ME180 protein receptor on the PVDF membrane. 
Next, immunoprecipitation assays were employed to pull down any ME180 
proteins that interacted with the BapL protein.  The anti-BapL antibody was coupled to 
protein G beads and allowed to interact with G. vaginalis surface proteins and ME180 
cervical epithelial cell proteins.  After an incubation, the bound protein was eluted and 
separated by SDS-PAGE.  The 23 kDa protein which interacted with the anti-BapL 
antibody was seen on the gel; however, other than a few contaminating proteins, the BapL 
protein is not seen on the gel.  This suggests that the BapL protein is not interacting with a 
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ME180 cervical epithelial cell surface protein.  Perhaps other yet unknown G. vaginalis 
surface proteins or carbohydrates interact with the ME180 cervical epithelial cells to allow 
for adherence.  These results could be confirmed by production of a bapL mutant strain of 
G. vaginalis and testing for its ability to adhere to cell lines.   
Finally, the BapL protein was expressed in the heterologous host S. aureus 
RN4220, which is a poor biofilm-producing bacterial strain.  S. aureus RN4220-bapL was 
able to produce a thicker biofilm than RN4220 with empty vector; however, when we 
tested production of the biofilm polysaccharide PNAG, it was shown that RN4220-bapL 
had a significant increase in production of PNAG.  Because S. aureus has a very efficient 
stress response system, it sometimes upregulates production of PNAG when large amounts 
of foreign DNA, such as the plasmid pRB473-bapL, are introduced.  To circumvent this 
problem, the plasmid pRB473-bapL was transduced into the S. aureus strain RN4220!ica; 
however, in this strain, no increase in biofilm formation was seen.  We hypothesized that 
perhaps the BapL protein was interacting with PNAG, allowing the carbohydrate to 
become anchored to the bacterial surface causing the increase in biofilm formation.  
However, a PNAG blot comparing secreted and cell surface associated PNAG from S. 
aureus RN4220!ica with empty vector or RN4220!ica-bapL demonstrated no difference 
between PNAG on the cell surface of bacteria with the bapL vector or empty vector control 
(data not shown).  Other heterologous hosts, like Bifidobacterium longum and B. subtilis, 
were assessed for their ability to express BapL; however, no bacteria tested have been able 
to express a cell surface associated BapL protein.  Because B. longum is closely related to 
G. vaginalis, a B. longum plasmid, pDOJHR, was assessed for its ability to replicate in G. 
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vaginalis; however, an efficient transformation protocol for G. vaginalis has not been 
identified, causing problems with detecting whether pDOJHR would be an appropriate 
vector for G. vaginalis. 
Until a genetic system is developed to allow for mutational analysis of G. vaginalis, 
the only way to ascertain what role the BapL protein is playing in biofilm formation is to 
potentially develop an antibody to the whole protein or larger portions of the protein and 
employ antibody inhibition assays with a number of antibodies which span the whole 
protein.  Also, it would be important to know which part of the protein harbors its active 
site; this could be accomplished by expressing truncated versions of the protein in a 
heterologous host and looking for a particular function, like adherence or biofilm 
formation.  However, since we were unable to show a particular function of the BapL 
protein, this experiment would be a shot in the dark, utilizing a potential function that may 
not actually be expressed. 
The scientific community is highly interested in the enzymatic degradation of 
bacterial biofilms, as biofilm formation is a cause of many medical, industrial and 
environmental problems (Chaignon, Sadovskaya et al. 2007).  An agent that could 
disintegrate the biofilm, releasing planktonic bacterian into the environment, would allow 
antibiotics to eliminate the infection with improved efficiency (Chaignon, Sadovskaya et 
al. 2007).  There is great need for an animal model of BV, since possible inflammatory 
effects of enzymatic treatment must first be studied before using the treatment in situ.   
 In conclusion, we have learned that G. vaginalis is more virulent than other BV-
associated anaerobes tested.  Its ability to produce a biofilm could play an important role in 
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the pathogenesis of BV, since biofilm bacteria are more resistant to chemicals like lactic 
acid and hydrogen peroxide.  A proteinaceous adhesin is involved in biofilm formation by 
G. vaginalis.  This is a significant result in that it allows researchers to focus their efforts 
on developing an enzyme that could be used in conjunction with antibiotic therapy, to 
degrade the biofilm and allow the constituent bacteria to be more susceptible to antibiotic 
challenge.  This pretreatment with a protease before addition of antibiotic may reduce the 
amount of relapse seen with BV.   
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APPENDIX A 
 
Percent reduction in biofilm mass of each enzyme concentration tested.
Bromelain 
Units 10 2 0.4 0.08 1.6E-2 3.2E-3 6.4E-4 1.3E-4 2.6E-5 5.1E-6 
pH 7.4 67.1 52 75.6 69.4 55.9 38 13.5 12.9 14 24.4 
pH 4.5 75.9 72.6 69.6 59 47.8 40.3 34.6 28.9 20.6 24.3 
Papain 
Units 10 2 0.4 0.08 1.6E-2 3.2E-3 6.4E-4 1.3E-4 2.6E-5 5.1E-6 
pH 7.4 84.5 88.9 83.3 62.6 32.4 8 0 0 0 0.1 
pH 4.5 88.5 88.6 85.9 61.7 32.3 26.4 19 13.5 12.3 15.1 
Ficin 
Units 5.78 1.12 2.3E-1 4.6E-2 9.3E-3 1.9E-3 3.7E-4 7.4E-5 1.4E-5 3.0E-6 
pH 7.4 91.8 88.9 66.1 59.2 46.1 16.9 0 5.3 9.2 21 
pH 4.5 92.7 75.2 77.8 74.5 41.1 24.5 22.2 26.9 21.1 20.6 
Pepsin 
Units 345 69 13.8 2.76 5.5E-1 1.1E-1 2.3E-2 4.4E-3 8.8E-4 1.8E-4 
pH 7.4 34.7 19.3 26.8 22.4 19.6 13.3 10.6 7 11.5 21.4 
pH 4.5 60.3 36.5 29.8 22 22.3 21 20.5 15.4 15.6 10 
Appendix A.  Percent reduction in biofilm mass of each enzyme 
concentration tested. 
Values shown are percent biofilm reduction for each enzyme unit tested. 
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